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ABSTRACT 
Biosensor technology is a rapidly expanding field of study in which tedious culturing 
techniques are being replaced by assays that use biorecognition elements such as antibodies and 
nucleic acids to detect biological entities. Biosensors have useful applications in areas such as food 
safety, water quality, clinical analysis, and defense again bioterrorism. Bench-top macro scale 
detection assays have limitations that restrict them to laboratory settings and require them to be 
performed by highly-trained personnel. Consequently, there has been a strong emphasis on 
developing technology that is portable and easy-to-use to enable its use in point-of-care and 
resource-limited settings.  Thus, the concept of a micro total analysis system (µTAS) in which all 
aspects of the biological assay are contained within a single device is very attractive. Benefits of 
µTASs over their macro scale counterparts, aside from portability and increased ease-of-use, 
include smaller sample sizes, reduced reagent consumption, decreased assay time, negligible 
contamination, and potential automation. 
Nucleic acid detection within µTASs is a commonly used method for the detection of cells 
and other microorganisms, as well as genomic analyses. A critical step in these assays is nucleic 
acid isolation within the microfluidic device. Miniaturizing nucleic acid isolation has led to the 
discovery of novel isolation techniques. Specific application and assay parameters determine 
desired characteristics of an optimal nucleic acid purification technique. Relevant parameters 
include sample type and size, device material and fabrication technologies available, as well as the 
pre- and post-isolation processes. The main nucleic acid isolation processes used within 
microfluidic devices are silica-based surfaces, functionalized paramagnetic beads, 
oligonucleotide-modified polymer surfaces, pH-dependent charged surfaces, aluminum oxide 
membranes, and liquid-phase isolation. 
  
 
 
  
A common process that follows isolation is nucleic acid amplification, and integrating both 
steps within the same device is key to developing a complete µTAS. Nucleic acid sequence-based 
amplification (NASBA) is an isothermal amplification technique of which the primary advantage 
over the standard polymerase chain reaction (PCR) is the elimination of necessary thermal cycles. 
In this research, nucleic acid isolation and NASBA were integrated within the same simple 
microchannel to realize highly sensitive detection of very low concentrations of messenger RNA 
(mRNA). The microchannels were fabricated simply and inexpensively from poly(methyl 
methacrylate) (PMMA) using hot-embossing and UV/ozone-assisted thermal bonding. Unique 
surface chemistry modifications, involving the immobilization of polyamidoamine (PAMAM) 
dendrimers and subsequent covalent attachment of thymidine oligonucleotide probes to the 
dendrimer periphery, were used to develop a surface to facilitate the capture of mRNA from 
Cryptosporidium parvum (C. parvum) oocyst lysate, while remaining a suitable surface for 
NASBA. Using this very simple device, successful mRNA isolation and NASBA-based 
amplification from as few as 30 C. parvum oocysts was achieved. 
An emerging area of point-of-care biosensor technology is that of paper-based sensors, and 
specifically, the lateral flow assay (LFA) has been very well-established. The main advantages of 
these types of sensors are that they are inexpensive, small, portable, disposable, easy-to-use, and 
require no external equipment or power source due to their capillary wicking ability. Traditionally, 
these biosensors are fabricated from cellulose-based fibers, which have fixed properties and 
limited chemical modification ability. Here, electrospun nanofibers have been presented as a new 
material for LFAs, since their properties are highly controllable and there are numerous materials 
from which the nanofibers can be made, giving countless surface modification possibilities. 
  
 
 
  
Poly(lactic acid) (PLA)-based nanofibers were optimized and incorporated into LFAs. Initial 
experiments demonstrated a successful one-step assay in which streptavidin-coated 
sulforhodamine B (SRB)-encapsulating liposomes were captured by anti-streptavidin antibodies 
adsorbed onto the nanofiber surface. Subsequently, an enzymatic sandwich immunoassay was 
developed for Escherichia coli (E. coli), and a limit of detection of 1.9x104 cells was achieved. 
Finally, functional polymers were used to demonstrate that the notorious problem of non-specific 
binding can be eliminated through the use of anti-fouling block copolymers. Functionalized 
electrospun nanofibers can thus be used to enhance paper-based assays and develop highly 
sensitive and specific biosensors possessing many significant advantages compared to traditional 
assays. 
Concluding from the microfluidic and LFA research presented, point-of-care biosensors 
can be developed in a variety of formats, each having their own benefits and limitations. By 
catering the characteristics of the assay to the parameters surrounding its application, an ideal, 
reliable biosensor can be realized. 
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CHAPTER 1 
MICROFLUIDIC NUCLEIC ACID ISOLATION 
Abstract 
Nucleic acid (NA) detection within micro total analysis systems (µTASs) for point-of-care 
use is a rapidly developing research area. For these systems to be maximally effective, efficient 
NA isolation from the raw sample is crucial, and using microfluidics assists in reducing sample 
sizes and reagent consumption, increases speed, avoids contamination, and enables automation. 
Through miniaturization into microchips, new techniques have been realized that would be 
unfavorable and inconvenient to use on the macro-scale, but provide an excellent platform for 
micro-scale NA purification. In this review, the complexities of NA isolation, as well as the 
considerations when choosing a technique for microfluidic NA isolation, are discussed, in addition 
to the numerous NA isolation techniques that have been miniaturized and integrated into 
microfluidic devices. Here, their advantages and disadvantages, as well as their (potential) 
applications, are included. The techniques presented include using silica-based surfaces, 
functionalized paramagnetic beads, oligonucleotide-modified polymer surfaces, pH-dependent 
charged surfaces, aluminum oxide membranes, and liquid-phase isolation. 
1 Introduction 
The development of bioassays for the detection of nucleic acids (NAs) has provided a 
monumental technological advancement in numerous fields of study with applications including 
pathogen detection in food, environmental, and clinical samples, as well as genetic analysis.[1-9] 
These assays provide several advantages over traditional microbiological methods that require the 
use of culturing techniques, such as reduced time and applicability to microorganisms and cells 
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that cannot be grown under laboratory conditions. A crucial part of NA detection assays is the 
isolation of the NAs. Without adequate purification of NAs from the raw samples, the sensitivity 
of the device is greatly decreased, and downstream processes, such as amplification and detection, 
could be inhibited.  
The detection of nucleic acids has been well-established using bench top, macro scale 
techniques; however, these techniques often require large specialized equipment, trained 
personnel, large sample sizes, and are generally time-consuming and expensive, which normally 
limits them to usage in centralized laboratory facilities. Consequently, there has been a strong 
interest in the development of portable point-of-care devices that can be used in resource-limited 
settings. As a result, the concept of a micro total analysis system (µTAS), or lab-on-a-chip, was 
presented by Manz et al.[10,11] These miniaturized analytical devices provide a significant 
improvement in performance. The major potential advantages of miniaturizing NA detection 
assays are that they require a much smaller sample volume, consume smaller quantities of reagents, 
and are faster and more sensitive due to their small size. Additionally, because these assays are 
carried out completely within a single device, the risk of contamination is almost eliminated and 
the system can be automatable. In order to take full advantage of miniaturized lab-on-a-chip 
systems for NA detection, isolation of NAs must be effectively done inside a device. Furthermore, 
unique advantages can and should be exploited, rather than just attempting to copy macro scale 
techniques and shrink them down to the micro scale, so that lab-on-a-chip systems can reach their 
full capabilities. Here, the non-user interference, non-contamination, fast diffusion, short reaction 
distances, fast heat transfer, and simple extraction capabilities are of ultimate importance.   
Isolation of NAs is a crucial step in a µTAS for the detection of cells and specific NA 
sequences in disease control, pharmacological studies, environmental protection, and fundamental 
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studies in which findings are tied to the identification of specific NA sequences. Critical sample 
aspects have to be considered prior to choosing the most appropriate NA isolation method in 
addition to the most obvious one, i.e. in the typically complex biological[12] and environmental[13] 
samples in which cells are contained. Cell lysis is the first step in NA isolation that can be 
accomplished using a variety of techniques both on- and off-chip, which have been reviewed 
extensively in literature.[12,14] The lysate contains several contaminants, including proteins, cellular 
membrane debris, polysaccharides, metabolites, ions, and other NAs,[15-17] that must be removed 
in the NA isolation process prior to subsequent analysis stages. The different types of NAs present 
in cells, including DNA, mRNA, rRNA, siRNA, etc., each have their own unique characteristics, 
such as function, mass, abundance, and location within the cells.[18]  
Another set of critical decision points is the type of NA to be isolated, the purpose for its 
isolation, and the complexity of required operations as these need to be realized in a limited space 
within a µTAS chip. Figure 1 summarizes relevant aspects of these decision points, which guide 
the researcher and user in the definition of critical device and assay characteristics. This review 
delivers a comprehensive overview of NA isolation techniques carried out within microdevices. 
The main techniques discussed within are silica-based surfaces, functionalized paramagnetic 
beads, oligonucleotide-modified polymer surfaces, pH-dependent charged surfaces, aluminum 
oxide membranes, and liquid-phase isolation. The different methods are compared in terms of 
advantages and disadvantages as well as their performance in specific applications. Integration of 
microfluidic NA isolation into complete µTASs enables the development of rapid, sensitive, and 
portable NA detection assays that can be used in resource-limited settings. A brief summary of the 
reviewed articles and critical analysis of the advantages and disadvantages of the different nucleic 
acid techniques is given in Table 1.1. 
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Figure 1.1: Critical decision points for choosing the appropriate NA isolation technique. Aspects that must 
be considered when deciding on a technique include the sample type, the specificity of the isolation, the 
isolation purpose, and the device characteristics and restrictions. 
 
2 Microfluidic Nucleic Acid Isolation Techniques 
2.1 Silica-Based Techniques 
Silica-based techniques were developed and investigated early on in microfluidic devices 
mimicking the successful silica-based isolation techniques of the Boom technology from the 1990s 
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that is currently commercialized by bioMérieux.[20-22] Here, the non-specific binding of NA 
molecules to silica is being exploited for separation from other sample components. Chaotropic 
salts, such as guanidinium and sodium iodide, shield the negative charge of the silica surface, 
which decreases NA repulsion, and dehydrate the silica and NAs creating a hydrophobic 
environment, so that favorable hydrogen bonding occurs between the NAs and silanol groups.[23] 
With the NAs bound to silica, a wash with an organic solvent, such as ethanol or isopropanol, 
results in highly purified NAs upon elution into a low-ionic strength solution.   
This chemical principle has been exploited in a variety of microfluidic designs combining 
the strengths of microfabrication and silica chemistry. Microscopic images of some of these 
platforms are depicted in Figure 1.2.  Microfluidic devices initially copied the macro-principle of 
packed silica beads or the inclusion of silica beads in polymer matrices. Shortly thereafter, silica 
microstructures were proposed as the next step in streamlining device manufacturing and 
customization. 
 
Figure 1.2: Microscopic images of the different silica-based surfaces used for NA isolation. a) silica beads 
within a microchannel (reprinted with permission from K. A. Wolfe, M. C. Breadmore, J. P. Ferrance, M. 
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E. Power, J. F. Conroy, P. M. Norris, J. P. Landers, Electrophoresis 2002, 23, 727–733. Copyright 2002 
WILEY-VCH Verlag GmbH.), b) silica beads incorporated into a sol-gel within a microchannel (reprinted 
with permission from K. A. Wolfe, M. C. Breadmore, J. P. Ferrance, M. E. Power, J. F. Conroy, P. M. 
Norris, J. P. Landers, Electrophoresis 2002, 23, 727–733. Copyright 2002 WILEY-VCH Verlag GmbH.), 
c) silica beads incorporated into a porous polymer monolith (reprinted with permission from A. Chatterjee, 
P. L. Mirer, E. Z. Santamaria, C. Klapperich, A. Sharon, A. F. Sauer-budge, Analytical chemistry 2010, 
82, 4344–4356. Copyright 2010 American Chemical Society.), d) silica-based sol-gel (reprinted with 
permission from Q. Wu, J. M. Bienvenue, B. J. Hassan, Y. C. Kwok, B. C. Giordano, P. M. Norris, J. P. 
Landers, J. P. Ferrance, Analytical chemistry 2006, 78, 5704–10. Copyright 2006 American Chemical 
Society.), e) silica-based porous polymer monolith (reprinted with permission from K. J. Shaw, L. Thain, 
P. T. Docker, C. E. Dyer, J. Greenman, G. M. Greenway, S. J. Haswell, Analytica chimica acta 2009, 652, 
231–3. Copyright 2009 Elsevier.), and f) silica micropillar array (reprinted with permission from L. A. 
Christel, K. Petersen, W. McMillan, M. A. Northrup, Journal of biomechanical engineering 1999, 121, 22–
7. Copyright 1999 ASME.). 
 
2.1.1 Packed Silica Beads 
Silica beads have been used in NA purification for over two decades, starting with benchtop 
assays using spin columns packed with silica beads.[20,29-31] This concept was miniaturized by 
incorporating silica beads into microcapillaries for more rapid NA isolation without the need for 
lengthy centrifugation.[32,33] For example, Tian et al. demonstrated the use of microcapillaries 
packed with only nanograms of silica beads to extract λ and prepurified human genomic DNA 
with approximately 70% efficiency, and reported a capacity of 10-30ng of DNA per mg of 
beads.[33] The majority of microfluidic devices constructed for the use of packed silica beads 
incorporate a weir structure, which acts as a frit to confine the beads to a specific location within 
the channel while still allowing fluid flow.[34] Zhong et al. developed a reusable device yielding 
an efficiency of 80% of λ DNA extracted [35]. Hagen et al. were the first to demonstrate successful 
on-chip isolation of RNA using packed silica beads.[36] Combining the NA isolation directly with 
an amplification reaction is the ultimate goal of a µTAS, and has been demonstrated for DNA 
isolation using packed silica beads and PCR amplification on-chip.[37,38] Here, it was important to 
thoroughly remove the solid phase extraction reagents, such as the chaotropic salts and organic 
solvents, as these are known PCR inhibitors.[38] These microfluidic devices contained separate 
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channels/reservoirs for DNA isolation and PCR amplification to further prevent inhibitors from 
interfering with PCR.[37,38] However, as Wolfe et al. also demonstrated, results were often not 
reproducible and the stability of the bead bed was poor resulting in destruction of the microchip 
after prolonged use,[24] which limits the usefulness of packed beads in µTAS applications. 
Additionally, issues such as bead compaction, increasing back pressure and decreasing flow due 
to the dynamic nature of bead packing are common drawbacks. A solution for several of these 
challenges has been found by entrapping the silica beads in polymer matrices within the 
microfluidic devices.[24] 
2.1.2 Silica Bead-Containing Matrices 
To improve upon the use of silica beads, they have been confined within porous materials, 
such as sol-gels and porous polymer monoliths. In the case of sol-gels, silica particles are 
incorporated into the gelation or polycondensation process[39] resulting in a monolith for NA 
isolation. Wolfe et al. investigated tetraethoxysilane (TEOS) sol-gels containing silica particles 
for DNA isolation.[24]  The authors focused on the identification of the most relevant factors that 
resulted in effective DNA isolation, which were the size of the silica beads, the material used for 
the sol-gel, the type of condensation reaction, and the monolith construction method. Breadmore 
et al. followed-up by optimizing the extraction conditions using this ideal silica bead-incorporating 
sol-gel, and extracting DNA from whole blood, bacterial DNA, and viral DNA.[23] Here, loading 
conditions were examined and the pH and flow rate were optimized. A decreased pH resulted in 
decreased repulsion between the silica surface and the DNA molecules, which in turn resulted in 
an increased DNA adsorption rate. This also enabled higher flow rates, and DNA extraction from 
whole blood was accomplished in under 15 minutes with an average efficiency of 67% over 10 
successive extractions. Subsequently, Legendre et al. were the first group to demonstrate 
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successful DNA isolation and PCR amplification within the same microdevice.[40] A significant 
limitation of using sol-gel matrices is the high heat required that in turn necessitates the use of 
glass as the microfluidic platform, which is a relatively expensive material to pattern. 
The Klapperich group has demonstrated a novel strategy to create porous polymer 
monoliths containing silica beads in order to use an inexpensive plastic-based microfluidic 
platform that can be patterned easily using hot-embossing. The significant decrease in 
manufacturing cost also allows these devices to be disposable, which obviously eliminates the risk 
of contamination between uses, and cleaning procedures that could be inadequate, too harsh 
leading to surface damage, or introduce additional inhibitors. These monoliths contain micro- and 
nano-scale pores, which allow fluid flow with low back pressures as well as a large surface area 
for NA adsorption.[41] Polymers, such as the cyclic olefin polymer, can be chosen that facilitate 
subsequent in-device detection due to their excellent optical qualities.[42,43] Initial designs achieved 
an extraction efficiency of 70±3%,[42] and were then successfully applied to a variety of conditions, 
including DNA from gram-positive and gram-negative bacteria in whole blood,[44] RNA from 
influenza virus type A in human nasopharyngeal aspirate,[43] DNA from Clostridium difficile in 
stool samples,[45] and DNA from Escherichia coli in urine.[46] Some of these assays have even been 
incorporated into µTASs integrating on-chip NA amplification.[45,47] While these methods of 
immobilizing silica beads within porous materials solve many of the problems associated with 
packed silica beads, they require additional fabrication steps once the microfluidic device is 
already fabricated, and they are occasionally difficult to reliably reuse. 
2.1.3 Silica Microstructures 
Silica microstructures have been developed to create a NA binding surface during the 
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microdevice fabrication itself, so that no post-fabrication processes are required. Since 
significantly less back pressure is observed in these devices in comparison to packed beads[35,36] 
and matrices,[33,42-44] higher flow rates can be realized, which in turn increases the throughput and 
allows for the processing of larger volumes. These devices are generally fabricated from silicon or 
glass substrates using reactive ion etching (RIE) to pattern the micropillars.[28,48-50]  Here, 
maximizing the available surface area and mixing within the device are key to optimizing their 
extraction efficiency. Thus, the efficacy of the isolation device is heavily dependent on the silica 
surface area, as well as microstructure and microchannel shapes.  
The surface area of the isolation device is determined by the size and density of the 
microstructures as well as the overall size of the isolation chamber. Generally, the surface area-to-
volume ratio (SA:V) is chosen as a compromise between maximizing surface area, ease of 
fabrication, and flow rate limitations due to back pressure, which ultimately dictates the extraction 
efficiency. It was found that the extraction efficiency scales positively with SA:V and negatively 
with flow rate. Thus, Cady et al. fabricated an array of square micropillars that were very densely 
distributed, which resulted in a very large SA:V of 4200cm2/mL.[48] With flow rates under 
10µL/min, a respectable extraction efficiency of 77% was obtained. In contrast, Christel et al. 
fabricated a device with a lower density of square micropillars resulting in a smaller SA:V, but 
were able to use a higher flow rate (30µL/min).[28] The lower extraction efficiency of 50% was 
compensated with an increased sample volume due to the higher feasible flow rate. The flow rate 
phenomenon was also demonstrated by West et al. within the same microdevice.[50] The extraction 
efficiency at 500µL/min was just 55% percent of that at 5µL/min.  
As indicated above, shape of the microstructures and of the microfluidic channels are 
important for determining an ideal flow pattern. Comparing microstructures with frustoconical and 
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pyramidal shapes, Wu et al. found that a bed of pyramidal pillars had a higher extraction efficiency 
than the frustoconical pillars. [51] It is hypothesized that the pyramidal pillars provide an increased 
flow disturbance, and therefore increase the number of DNA molecules that contact the binding 
surface. In the case of the microfluidic channel dimensions, a wider, shorter channel will reduce 
the hydrodynamic resistance and allow for higher flow rate, while a thinner, longer channel 
increases it.[50] If the device will be used for small sample volumes that contain little target NA, 
then a thin, long channel would be better to maximize the number of NAs that bind. For large 
sample volumes that contain more target, a wide, short channel would be more ideal as it would 
allow for a higher flow rate, and thus increased throughput, while compromising on the extraction 
efficiency. Figure 1.3 contains a diagram summarizing the design considerations for fabricating 
silica microstructures within microfluidic channels for NA isolation.  
The integration of silica microstructure technology into a µTAS, including NA 
amplification and detection steps, has been demonstrated. Wu et al. have extracted DNA from 
A549 cells and whole blood with subsequent on-chip loop-mediated isothermal amplification 
(LAMP) and fluorescence detection.[51] They were able to achieve extraction efficiencies that were 
equal to or better than a commercial kit. Cady et al. developed a microdevice that detects Listeria 
monocytogenes in 45 minutes with a limit of detection (LOD) of around 104 cells.[52] This device 
used an array of square micropillars for DNA isolation and real-time PCR to amplify and 
fluorescently detect the DNA.  
In summary, silica microstructure arrays can be used as an effective NA isolation platform. 
The main disadvantages of this isolation technique are that the devices are constructed from 
relatively expensive materials and the manufacturing process is complex, time-consuming, and 
requires access to a cleanroom, which is very costly. 
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Figure 1.3: Summary of design considerations for the fabrication of silica microstructures for NA isolation. 
Critical characteristics of the microstructures include their size, density, and shape. Selection of the 
appropriate dimensions for the microfluidic channels is also very important and should be made based on 
the sample size and concentration. 
 
2.1.4 Other Silica-Based Surfaces 
Other silica-based surfaces for NA isolation have been used within microfluidic devices, 
including silicate-based porous polymer monoliths and silica membranes in order to avoid issues 
such as bead compaction, uneven distribution of beads within matrices, and the high cost of 
microfabrication. Several groups have used porous polymer monoliths made from tetramethyl 
orthosilicate (TMOS)[26,53] and potassium silicate solutions.[54-56] For example, Wu et al. were the 
first to use TMOS monoliths for DNA extraction, demonstrating an extraction efficiency of 85% 
with λ DNA in solution and 70% with human genomic DNA in whole blood.[26] Wen et al. 
developed a two-stage system in which proteins were removed from the sample using a C18 
reversed-phase monolith, and subsequently DNA from whole blood with a TMOS monolith.[53] 
With their design, only 38% of the DNA was extracted without the protein removal stage, but with 
this stage, 69% of the DNA was retained. We propose that this type of pre-isolation protein 
removal could be applied to other technologies to achieve a higher extraction efficiency. Potassium 
silicate monoliths have been used to successfully extract DNA from buccal[54] and Mus musculus 
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cells,[56] as well as RNA from rat hepatocytes.[55] Kashkary et al. were able to isolate DNA from 
very small, dilute samples containing less than 15ng of DNA.[56] With small volumes of dilute 
sample, it is traditionally[57] suggested to use carrier RNA to reach sufficient extraction 
efficiencies.[27] However, Kashkary et al. were able to extract DNA from these sample without the 
use of a carrier, and achieved an extraction efficiency of approximately 85%.[56] Porous polymer 
monoliths without silica beads still possess a very large SA:V, and have been proven to sufficiently 
isolate NAs. 
A yet different format for silica-based NA isolation is the use of silica membranes 
consisting of a network of glass fibers. Typically, the glass fiber membranes are integrated into 
the devices by simply physically securing them within a chamber. This approach has been used 
within complete µTASs to perform the NA purification step of the assays before amplification by 
PCR. The membranes have been used to isolate DNA and RNA from several different sample 
types, including bacterial DNA from Bacillus cereus and viral RNA from HIV I in saliva,[58] and 
G6PDH and BCR-ABL cancerous RNA transcripts from K562 cells in blood.[59] Using their device 
incorporating on-chip lysis, NA isolation, PCR (or RT-PCR), amplicon labeling, and detection, 
Chen et al. were able to achieve LODs of 103-104 B. cereus cells and 105 HIV virions/mL.[58] 
Kokoris et al. were able to detect cancer RNA transcripts from as few as 10 malignant cells.[59] In 
all cases, the NA isolation step within these devices was essential for achieving such low LODs. 
Schematics of each of the silica-based isolation techniques can be seen in Figure 1.4. 
2.2 Paramagnetic Bead-Based Techniques 
Separation assays using paramagnetic beads have been extensively used since the 1970s, 
and have been thoroughly reviewed in the literature.[60-63] Furthermore, paramagnetic beads have 
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Figure 1.4: Schematic summary of silica-based NA isolation techniques. Silica-based isolation methods 
include: packed silica beads (A), silica beads embedded in matrices (B), silica microstructures (C), silica-
based porous monoliths (D), silica membranes (E), and silica-coated paramagnetic beads (F). 
 
been integrated into biological assays within microfluidic devices.[64,65] Paramagnetic beads have 
several advantages over packed bead beds in NA isolation assays. Crude samples with many solid 
contaminants of varying sizes are more easily dealt with as there is no issue of clogging due to 
densely-packed beads. A wide range of sample volumes can also be accommodated, since the 
beads still possess a large SA:V and the flow rate is not restricted by small pore sizes between 
packed beads and the weir structure. These advantages are possible due to the ability of the 
paramagnetic beads to be manipulated by a magnetic field. This allows the beads to be freely 
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suspended in the sample solution, which maximizes the interaction between the beads and sample, 
and it allows the beads to be collected using a magnetic field rather than centrifugation or filtration. 
Additional benefits are realized when using paramagnetic beads within a microfluidic device 
because much fewer beads can be used regardless of the sample volume, which reduces cost, and 
a lower magnetic field strength can be used, since the platform is a micro scale device. However, 
requiring a magnetic field puts limitations on the design of the microfluidic chip. The type of 
material and its thickness will affect the strength of the magnetic field,[64] and the microchannel 
should be designed to minimize bead loss. Both specific and non-specific NA isolation have been 
demonstrated through the use of paramagnetic beads with different surface modifications. 
2.2.1 Silica-Coated Paramagnetic Beads 
The general technique of using silica beads as described above can be enhanced by using 
silica-coated paramagnetic beads. Instead of being packed and confined to the chamber using a 
weir, paramagnetic silica beads can be free in solution and then be collected using a magnetic field, 
which increases the available silica surface area for NA binding. A schematic of this technique is 
shown in Figure 1.4. A variety of techniques have been employed for the washing and elution 
phases of NA isolation. There are conventional techniques that use a magnetic field to hold the 
beads stationary while washing buffers flow through the microchannels, and there are more 
unconventional techniques that use a magnetic field to move the paramagnetic beads through 
stationary washing solutions. Duarte et al. compared polyester-toner (PeT) devices versus glass 
devices using paramagnetic beads and a rotating magnetic field for agitation, and showed that the 
extraction efficiency was slightly higher for PeT (~70%) than glass (~64%) with elution occurring 
much more rapidly in PeT than in glass (73.5% vs. 34% in the first 6µL).[64] It was hypothesized 
that the thinner walls of the PeT device allowed a stronger magnetic field presence in the 
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microchannel, which increased the agitation of the beads resulting in faster elution. They also 
demonstrated scaling up to 8 PeT microchannels, but also showed that the nonhomogeneity of the 
magnetic field between channels results in a lower average extraction efficiency across all the 
channels. Lien et al. integrated silica paramagnetic bead isolation into a complete µTAS for 
detecting α-thalassemia-1 genetic deletions in saliva samples with an LOD of 12 pg/µL.[65]  
Microfluidic devices using stationary solutions and flowing paramagnetic beads have been 
developed with varying geometries and complexities. Bordelon et al. used glass tubes with a series 
of solutions separated by air bubbles via surface tension and used a donut-shaped magnet to move 
paramagnetic beads successively through the solutions.[66] This resulted in an LOD for RSV-
infected HEp-2 cells that was comparable to that of a commercially available kit, while providing 
a significant improvement in handling. Hydrophobic immiscible liquids have also been used to 
separate the aqueous washing and elution solutions,[67] as well as to serve as the washing phase 
between the binding and elution phases.[68] By using immiscible liquids instead of air, the 
carryover of the aqueous solutions between phases is very small.[68] On the downside of using 
silica-coated paramagnetic beads, they still require the use of chaotropic salts and organic solvents, 
which can interfere with downstream processes such as NA amplification. 
2.2.2 Paramagnetic Beads with Switchable Charges 
Similarly to silica surfaces, charged surfaces can also be used to isolate NAs from complex 
samples due to the charged nature of NAs. Some materials can possess different surface charges 
depending on the pH of the solution in contact with them. This phenomenon has been utilized for 
NA isolation using materials that switch between a positive charge for binding the negative NAs, 
and a negative charge for elution. This type of material has been coated onto paramagnetic beads 
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to take advantage of their additional benefits. Thus, Liu et al. used beads coated with a commercial 
material with switchable charges in a microfluidic device that performed both total RNA extraction 
from T98 cells and reverse transcription (RT).[69] With the lysate in a buffer with pH lower than 
6.0, the paramagnetic beads are positively charged, which causes the NAs in the sample bind to 
them, and the contaminants can be washed away. With their microdevice, they were then able to 
isolate a slightly higher amount of RNA (47.2µg) compared to the manual procedure (32.5µg) 
using the same type of beads. These types of magnetic beads have also been incorporated into 
complete µTASs. Lien et al. demonstrated gDNA isolation from leukocytes in a device that 
included leukocyte purification, lysis, gDNA extraction, and PCR on-chip for the purpose of 
detecting single nucleotide polymorphism genotyping.[70] Furthermore, a multiplex µTAS that can 
handle 10 samples has been developed by Liu et al. that can detect Mycobacterium tuberculosis 
starting from saliva samples straight through to a visible fluorescent signal.[71] They were able to 
achieve an excellent LOD of just 10 bacteria, which demonstrates the great potential of using 
paramagnetic beads with switchable charges to develop highly sensitive µTASs. However, as a 
general disadvantage of these methods, it needs to be emphasized that this process still necessitates 
the use of DNases and RNases to degrade the unwanted types of NAs. 
2.2.3 Paramagnetic Beads Coated with Oligo-dT 
Non-specific isolation of all NAs sometimes requires additional purification steps to 
narrow down the sample to a specific target NA type. The large number of NAs in some samples 
can even saturate the silica surface thereby lowering the extraction efficiency of the target NAs. In 
eukaryotic organisms, most messenger RNA (mRNA) possess a poly-adenosine (poly-A) tail, and 
an elegant way to increase the specificity of NA isolation is the detection of mRNA using the 
thymidine oligonucleotide, oligo-dT. The oligo-dT will hybridize with the poly-A tail of all the 
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mRNA molecules, while other types of NAs do not bind. An additional bonus of mRNA detection 
is the fact that only viable organisms will have these present within the cell in contrast to general 
DNA sequence detection.[72] Specific mRNA extraction is also advantageous, since the quantity of 
mRNA is very small compared to total RNA yet multiple copies exist for each sequence. With 
oligo-dT-conjugated paramagnetic beads, Jiang and Harrison were able to isolate just 2.8ng of 
mRNA for the rare Drosophila Melanogaster bicoid gene in 0.85mg of total RNA (50% mRNA 
extraction efficiency) within a very simple Y-shaped device.[73] Marcus et al. reported isolations 
of picogram and subpicogram quantities of mRNA from single cells with an extraction efficiency 
of 80% using a more complex device that incorporated cell capture, cell lysis, mRNA purification, 
complimentary DNA (cDNA) synthesis, and cDNA purification.[74] Isolation with oligo-dT 
paramagnetic beads has also been scaled-up for high throughput as well as simplified for rapidity 
by Berry et al. in which they developed a device with standardized dimensions of microtiter plates 
for extracting 384 or 1536 samples in parallel.[75] In their device, the beads are magnetically pulled 
through an immiscible hydrophobic phase that separates the binding and elution solutions, and the 
mRNA bound to the beads is purified with hydrophilic contaminants remaining confined within 
the aqueous binding phase and the hydrophobic contaminants remaining confined within the 
immiscible hydrophobic phase. With this technique, mRNA from over 100 samples was isolated 
in just 10s. The principle of specific RNA isolation can be further specialized by moving toward 
the isolation of specific sequences as discussed next.   
2.2.4 Paramagnetic Beads Coated with Specific Sequences 
Modifying paramagnetic beads with specific oligonucleotide sequences is very 
advantageous as it facilitates the possibility of direct detection of target NA sequences without 
further purification, since the NA sequences of interest simply hybridize complimentarily to the 
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paramagnetic beads while the rest of the NAs and contaminants are washed away. An important 
parameter that needs to be considered when developing probe-conjugated paramagnetic bead-
based isolation systems is the density of probes on the surfaces of the magnetic beads. If the probe 
density is too high, then isolation can be hindered by steric effects.[76,77] Conversely, if the probes 
are too sparse, non-specific binding to the bead surface can occur and contaminate the sample.[76] 
In an attempt to avoid steric hindrance when isolating circular Escherichia coli RNA, Yeung and 
Hsing introduced the sample into a solution of biotinylated specific oligonucleotide probes for 
binding, and then this solution was transferred to the streptavidinylated paramagnetic beads for 
capture.[76] This strategy was integrated into a complete µTAS, and an LOD of 102-103 bacteria 
was achieved. Several other µTASs have been developed using paramagnetic beads modified with 
specific sequences that are both rapid and sensitive. These include µTASs for detecting nervous 
necrosis virus RNA from water samples that achieved an LOD of 10-100fg,[78] methicillin-resistant 
Staphylococcus aureus DNA from sputum, serum, and milk samples with an LOD of 10fg/mL,[79] 
and influenza A and B viral RNA with LODs of 101-102 viruses.[80] The specific nature of the NA 
isolation in these systems enabled detection with very low LODs. However, the isolation of 
specific sequences may be hindered by the presence of large concentrations of bulk DNA and RNA 
present in a sample, and this requires specific attention, potentially with the development of a two-
step procedure. As pointed out in Table 1.1, a general disadvantage of using magnetic beads is the 
sometimes prohibiting costs involved with high quality paramagnetic beads and at this point it 
limits their widespread use in developing areas. Figure 1.5 shows schematics of paramagnetic 
bead-based methods of NA isolation. 
  
  19 
 
Figure 1.5: Schematic summary of paramagnetic bead-based NA isolation techniques. Isolation methods 
using paramagnetic beads include: paramagnetic beads with switchable charges (A), paramagnetic beads 
coated with oligo-dT probes (B), and paramagnetic beads coated with specific sequence oligonucleotide 
probes (C). 
 
2.3 Specific Surface Modifications 
Isolation of NAs can also be achieved by modifying a surface directly with 
oligonucleotides as well as using specific surfaces that will non-specifically bind NAs under 
certain buffer conditions. These methods are represented in the schematics in Figure 1.6 and are 
discussed below.  
2.3.1 Oligonucleotides on Polymer Surfaces 
Modifying polymer surfaces covalently with oligonucleotides for NA isolation is very 
advantageous as there is no need for beads, so restrictions on the dimensions of the device for 
confining the beads (packing or magnetic) are eliminated, as well as the cost of the beads. Synthesis 
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of these surfaces can be easily added to the manufacturing process; however, limiting the synthesis 
to isolated locations is only achievable using more complicated procedures, such as masks or 
alternate assembly designs.[81] Ultimately, microstructured fluidic channels similar to those 
presented above in the silica microstructured devices that are also modified with these surfaces 
should become most interesting, and cohesively create a platform for highly sensitive NA isolation.  
Both oligo-dT and specific oligonucleotide probes have been immobilized onto porous 
polymer surfaces. Satterfield et al. demonstrated extraction of rat liver mRNA using oligo-dT30-
modified methacrylate polymer monoliths, and were able to extract greater than 16µg of mRNA 
in just 0.4µL of monolith with an extraction efficiency of 70%.[82] Root et al. used specific 
oligonucleotide probes to isolate the gag region of the HIV virus in serum samples, and achieved 
successful purification from concentrations as low as 37.5 copies/µL.[83] Creating these modified 
polymers within microfluidic channels requires additional steps that include reactive ingredients 
that could inhibit isolation or other processes if they are not adequately washed out; however, these 
polymers are needed to provide the additional surface area to immobilize a sufficient number of 
capture probes for effective NA isolation. Our group developed a method for modifying 
microchannels with a high immobilization efficiency without the need for synthesis of a porous 
matrix. Using 5th-generation polyamidoamine dendrimers, oligo-dT probes were immobilized onto 
their periphery resulting in a high immobilization efficiency. Compared to probes immobilized in 
a monolayer on the surface of the microchannel, the use of dendrimers resulted in an 18-fold 
increase in the number of oligo-dT probes immobilized and a 16-fold increase in the amount of 
complimentary target captured.[72] Using probe modified surfaces as the isolation media would be 
very advantageous for µTAS applications in resource-limited locations as it simplifies the 
operation and reduces the cost of the device. 
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2.3.2 Chitosan-Coated Beads 
The Landers group has developed an NA isolation technique using chitosan-coated beads. 
This is a non-specific isolation technique in which chitosan has a pH-dependent charge and can 
bind NAs at pH 5 and elute them at pH 9, which has great advantages over silica beads in that this 
procedure uses all aqueous buffers as opposed to chaotropic buffers and organic solvents that can 
inhibit downstream processes. Although chitosan surfaces have a lower overall capacity for NAs 
compared to silica surfaces, while still being sufficiently high for the desired applications, the 
elution of NAs is much faster with chitosan surfaces within a small elution volume. Hagen et al. 
found extraction efficiencies of 71% for chitosan beads versus 53% for silica beads.[84]  Chitosan-
coated beads have also been used within microfluidic devices to isolate RNA from buccal cells,[84] 
DNA from whole blood,[85] and RNA from the influenza A virus.[86] Advantages and disadvantages 
mentioned in general for bead-based microfluidic devices obviously also apply to these chitosan 
beads (see Table 1.1). 
2.3.3 Aluminum Oxide Membranes 
Aluminum oxide membranes (AOMs) can be used to isolate NAs in a similar way to silica 
membranes. A high salt concentration causes the NAs to bind to the membrane surface tightly. A 
positive characteristic of these membranes that has been exploited is that they will not inhibit PCR 
if the membrane volume relative to the PCR reaction volume is maintained below a certain 
threshold.[87] The NAs will in fact stay bound to the membrane in the presence of the PCR mix, so 
it can be used as a template in successive PCR reactions. Oblath et al. discovered that the NAs can 
be eluted when bovine serum albumin and Taq polymerase are added to the PCR reaction 
mixture.[88] AOMs have been incorporated into microdevices capable of isolating and amplifying 
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both RNA and DNA. Kim et al. successfully extracted and PCR-amplified DNA from just 300 
Bacillus cereus cells and 2000 synthetic HIV RNA gag fragments.[87] A multiplex µTAS has also 
been developed that is capable of extracting, amplifying, and detecting just 300fg (100-125 copies) 
of genomic DNA from both methicillin-susceptible and methicillin-resistant Staphylococcus 
aureus.[88] The compatibility with downstream processing of samples makes AOMs very attractive 
NA isolation platforms. However, due to their tight binding of NAs, it is difficult to replenish the 
surface of the membrane, and replacement of the membrane with every sample presents its own 
challenges. 
2.3.4 Photo-Activated Polycarbonate Surfaces 
Photo-activated polycarbonate (PC) surfaces have been shown to non-specifically bind 
NAs in the presence of high concentrations of polyethylene glycol (PEG) and NaCl, based on the 
bench top demonstration of DNA binding to carboxylated magnetic beads by Hawkins et al.[89] 
Photo-activation of the PC creates a carboxylated surface, and the NA binding occurs in an 
analogous way to using silica surfaces. However, PC patterning is much easier and less expensive 
than silica surfaces, since it can be patterned using hot-embossing. Also, sodium polyanethole 
sulfonate (SPS), a commonly used anticoagulant for whole blood samples, is a known PCR 
inhibitor, and it binds to silica in the presence of chaotropic salts, but not to PC.[90] This technology 
was implemented into microfluidic devices, and first characterized in a sheet format by Xu et al., 
achieving a loading density of 3.9 pmol/cm2 for ssDNA sequencing ladders.[91] Based on these 
promising results, devices with micropost arrays within channels were fabricated and characterized 
by Witek et al., and an extraction efficiency of 85% was attained for gDNA from whole cell 
lysates.[92] This technology has also been scaled up to a 96x format compatible with 96-well 
microtiter plates,[93] and has been used to purify gDNA and total RNA from whole cell lysates with 
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efficiencies of 63% and 73%, respectively.[90] These extractions were performed very quickly with 
96 purifications taking less than 30 minutes, and the inexpensive nature of these devices enables 
them to be disposable. A limitation of using these surfaces could be the stability of the photo-
activated surfaces over time and under various temperature conditions as is the case for 
applications in resource-limited settings. 
2.3.5 Amine-Coated Surfaces 
Amine-coated surfaces have been investigated for use in NA isolation within microfluidic 
chips. Amine groups are positively charged in buffers with a lower pH, and will non-specifically 
bind NAs through electrostatic interactions. These surfaces do not require buffers that contain 
species that can inhibit downstream processes, and amine surfaces can be generated in many ways 
on a variety of surfaces, which makes this technique simple and robust. Nakagawa et al. produced 
amine groups using amino silane compounds, and bound λ DNA and gDNA from whole blood 
using a buffer with pH 7.5 and eluted it using pH 10.6 buffer.[94] They were able to achieve 
efficiencies of up to 60%. These surfaces can successfully extract NAs; however, the solely 
electrostatic nature of the immobilization presents a surface that will attract any species with a 
negative charge. Also, the high pH of the elution buffer can also present problems for subsequent 
processes or necessitate pH adjustment. 
2.4 Liquid-Phase Isolation Techniques 
There have been other isolation techniques developed within microfluidic devices that do 
not use surfaces or probes as a means for binding NAs. These techniques utilize solution chemistry 
to separate NAs from the sample contaminants. 
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Figure 1.6: Schematic summary of NA isolation techniques using specific surface modifications. These 
techniques include: oligo-dT probes immobilized directly on the channel surface (A), oligo-dT probes 
immobilized on the periphery of dendrimers (B), oligonucleotide probes immobilized within a porous 
matrix (C), chitosan-coated packed beads (D), aluminum oxide membranes (E), photo-activated 
polycarbonate microstructures (F), and amine-coated surfaces (G). 
 
2.4.1 Electrophoretic Techniques 
Different techniques based on electrophoresis have been developed and integrated into 
microfluidic devices. For example, isotachophoresis (ITP) uses a two-buffer system containing a 
leading electrolyte and a trailing electrolyte that are designed to have electrophoretic mobilities 
higher and lower than the NAs, respectively. The trailing electrolyte should have a mobility lower 
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than the NA, but higher than the negative impurities. Positive impurities do not migrate in the same 
direction as the negative NAs. When an electric field is applied across the two buffers, the NAs 
migrate to the interface between the two buffers where an electric field gradient exists. This 
technology was demonstrated in a microchip by Persat et al., with λ DNA achieving 100% 
extraction efficiency and extractions from whole blood achieving 30-70% efficiency.[95] Marshall 
et al. detected Plasmodium falciparvum DNA in whole blood with an LOD of 500 parasites.[96]  
Another example is dielectrophoretic trapping. With this method, DNA can be trapped in 
areas of extremely large electric field gradients due to its polar nature. This is the same technology 
used by Nanogen Inc. to trap cells within their microdevices.[97] Prinz et al. successfully trapped 
chromatin from lysed Escherichia coli cells and separated it from other sample contaminants.[98] 
Here, an alternating current (AC) field was used to trap the chromatin, and a small direct current 
(DC) field was used to remove contaminants, including proteins, RNA, and cellular debris. The 
microdevice was designed with a specific geometry that controlled the location of the areas of high 
electric field gradient, and thus trapping areas. 
Gel-electrophoresis has also been demonstrated within a microfluidic device for extraction 
of RNA from complex samples. Here, a DC constant current is applied to the microchannel 
containing the sample and negatively charged species migrate across with smaller, more charged 
species moving more quickly than the larger, less charged species. Using this technique, low 
molecular weight RNA was isolated from Escherichia coli and Streptococcus thermophiles 
bacteria lysate samples.[99] This was possible due to the small, highly negative nature of these 
RNAs and the gel, which acted as a cut-off filter for higher molecular weight species such as 
protein, cellular debris, and genomic DNA. This is another example of an established macro-scale 
process being scaled down into a microfluidic device. 
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These electrophoretic-based techniques for NA isolation have several advantages over 
typical solid-phase extraction. Firstly, there is no need for external pumps for pressure-driven flow; 
only a voltage source, so the overall size of the device is decreased. Secondly, the use of chaotropic 
salts and organic solvents that inhibit downstream processes is not necessary. Thirdly, these 
techniques are generally insensitive to the type substrate material used. Also, for ITP, the geometry 
of the microchannels does not affect the process. These advantages make these techniques 
attractive for the isolation of NAs, but there are some concerns as well. Most importantly, none of 
these technologies have been integrated into a microchip that also performs on-chip amplification 
or detection; they all require removal of the sample via pipette. Also, the electrophoretic mobility 
of the NAs to be isolated must be known, which varies with charge and dynamic size of the 
NAs.[100]  
2.4.2 Organic Liquid Isolation 
The well-established macro-scale technique of liquid-phase phenol-chloroform extraction 
has also been miniaturized and performed within a microfluidic device. In this process, proteins 
and cellular debris partition from the aqueous sample phase into the organic phase as it is an 
energetically-favorable transition. The main advantage of this technique over solid-phase 
extraction is that the purification efficiency is higher, which enables the successful extraction of 
minute quantities of NAs. In fact, using this technique on-chip, Zhang et al. were able to isolate 
DNA and RNA from 5000 bacterial cells down to just one cell in 1µL or 125nL of sample.[101] 
Furthermore, the resulting purified NAs were amplified via PCR in the same chambers where 
isolation occurred. This indicates the successful removal of inhibitors and isolation of target NAs. 
Sensitivity was likely improved by performing isolation and amplification within the same 
chamber, since NA losses during sample transfer are avoided, as also demonstrated previously in 
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our research.[72] From this range of bacterial sample sizes, the extraction efficiencies were an 
impressive 85-120%. The main disadvantage of this technique is the use of extremely hazardous 
organic solvents, which requires safe handling and disposal. This would clearly limit the use of 
these devices in most in-field, on-site, and resource-limited applications. 
3 Conclusions 
Summarized in Table 1.1, the NA isolation techniques discussed in this review demonstrate 
the potential to develop µTAS devices capable of being used in point-of-care settings. By 
miniaturizing these processes and integrating them into a microfluidic device, many advantages 
are realized compared to their macro scale bench top counterparts. Miniaturization also gives 
researchers numerous options for isolating NAs, as many different techniques have been 
demonstrated. This means the isolation method can be selected based on which technique is most 
suitable for the assay parameters, including sample type and size, device material and fabrication 
technologies available, as well as the pre- and post-isolation processes, instead of requiring the 
device and assay to be designed around the isolation technique. Scaling down NA purification into 
a microfluidic device can make the process more cost effective, faster, automatable, and reduce 
contamination. In addition, it enables these technologies to be multiplexed to handle multiple 
samples simultaneously, and provides a platform for high-throughput sample processing. 
Although the development of NA isolation techniques within microdevices has advanced 
significantly with many different techniques being discovered, there is still great room for 
improvement both with the techniques themselves and integration and compatibility with other 
processes, such as cell lysis, NA amplification, and detection. Also, the ability to achieve close to 
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Table 1.1: Summary of Nucleic Acid Isolation Techniques 
 
  
 
Isolation 
Technique 
Advantages Disadvantages Isolation Application Ref. 
Packed Silica 
Beads 
 Well established 
 Simple concept 
 Bead compaction 
leading to 
increased back 
pressure and 
decreased flow 
 Not reliably 
reusable 
 Uses solutions that 
inhibit 
amplification 
 Device restrictions 
RNA from neat semen, mock 
semen stain, and alveolar 
rhabdomyosarcoma 
[36] 
B. anthracis DNA in whole 
blood and B. pertussis DNA 
in nasal aspirate 
[37] 
Short tedem repeat (STR) 
DNA fragments in whole 
blood and semen 
[38] 
Sol-gels 
incorporating 
silica beads 
 Large SA:V 
 Generally 
reusable 
 Requires post-
fabrication 
processing 
 High fabrication 
temperature 
 Expensive 
substrate 
 Uneven bead 
distribution 
 Uses solutions that 
inhibit 
amplification 
S. typhimurium and B. 
anthracis DNA in whole 
blood 
[23] 
Genomic DNA in whole 
blood and B. anthracis DNA 
in a nasal swab 
[40] 
Porous polymer 
monoliths 
incorporating 
silica beads 
 Large SA:V 
 Disposable (one-
time use) 
 Inexpensive 
 Requires post-
fabrication 
processing 
 Uneven bead 
distribution 
 Uses solutions that 
inhibit 
amplification 
Influenza A viral RNA in 
cultured mammalian (MDCK) 
cells 
[43] 
Influenza A and B viral RNA 
in a nasopharyngeal swab and 
aspirate 
[47] 
E. coli DNA in urine [46] 
E. coli, B. subtilis, and E. 
faecalis DNA in whole blood 
[44] 
C. difficile DNA in stool [45] 
Fabricated Silica 
Microstructures 
 No post-
fabrication 
processing 
 Reusable 
 Higher flow rates 
feasible 
 Expensive 
substrate 
 Long, complex, 
expensive 
fabrication process 
 Lower SA:V 
 Uses solutions that 
inhibit 
amplification 
Genomic DNA from 
leukocytes in whole blood 
[49] 
DNA from salmon sperm 
cells 
[50] 
Genomic DNA in whole 
blood and A549 cell 
suspensions 
[51] 
Bacterial DNA from L. 
monocytogenes 
[52] 
Silicate-based 
Porous Monolith 
 Large SA:V 
 Requires post-
fabrication 
processing 
Genomic DNA in whole 
blood 
[26, 
53] 
Genomic DNA from buccal 
cells 
[54] 
RNA from rat hepatocytes [55] 
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 Uses solutions that 
inhibit 
amplification 
DNA from Mus musculus 
cells 
[56] 
Silica 
Membrane 
 Easy integration 
into microfluidic 
device 
 Expensive 
 Uses solutions that 
inhibit 
amplification 
B. cereus DNA and HIV I 
viral RNA in saliva 
[58] 
G6PDH and BCR-ABL 
cancer transcripts in K562 
cells 
[59] 
Silica-coated 
Paramagnetic 
Beads 
 High flow rates 
possible 
 Large SA:V 
 Requires magnetic 
field 
 Device material 
and dimensions 
restrictions 
 Uses solutions that 
inhibit 
amplification 
 Beads are 
expensive 
Genomic DNA in whole 
blood 
[64] 
α-thalassemia-1 DNA genetic 
deletions in saliva 
[65] 
RNA from RSV-infected 
HEp-2 cells 
[66] 
RNA from HIV-1 virus in 
plasma 
[68] 
Paramagnetic 
Beads with 
Switchable 
Charges 
 High flow rates 
possible 
 Large SA:V 
 Uses pH instead 
of PCR-inhibiting 
solutions 
 Requires magnetic 
field 
 Device material 
and dimensions 
restrictions 
 Beads are 
expensive 
RNA from T98 cells [69] 
Single nucleotide 
polymorphism genotyping of 
genomic DNA from 
leukocytes 
[70] 
DNA from M. tuberculosis in 
saliva 
[71] 
Paramagnetic 
Beads Coated 
with Oligo-dT 
 Only captures 
mRNA 
 Detects viable 
organisms 
 High flow rates 
possible 
 Large SA:V 
 mRNA poly-A tail 
is necessary 
 Probe density 
restrictions 
 Requires magnetic 
field 
 Device material 
and dimensions 
restrictions 
 Beads are 
expensive 
Bicoid gene mRNA from 
Drosophila Melanogaster 
[73] 
mRNA from a single 
NIH/3T3 cell 
[74] 
Multiplex mRNA isolation 
from MCF-7 cells 
[75] 
Paramagnetic 
Beads Coated 
with Specific 
Sequences 
 Direct capture of 
target 
 Lower LODs 
 Probe density 
restrictions 
 Requires magnetic 
field 
 Device material 
and dimensions 
restrictions 
 Beads are 
expensive 
Circular RNA from E. coli [76] 
RNA from nervous necrosis 
virus in water samples 
[78] 
DNA from methicillin-
resistant S. aureus in sputum, 
serum, and milk 
[79] 
RNA from influenza A and B 
viruses 
[80] 
 No device 
restrictions 
mRNA from C. parvum [72] 
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Oligonucleotides 
on Polymer 
Surfaces 
 Large SA:V  Requires post-
fabrication 
processing 
 Uses reactive 
substances that can 
inhibit downstream 
processes 
mRNA from rat liver cells [82] 
Gag region RNA from HIV 
viruses in serum 
[83] 
Chitosan-coated 
Beads 
 Uses pH instead 
of PCR-inhibiting 
solutions 
 Fast elution in 
small volume 
 Lower capacity 
 Bead compaction 
leading to 
increased back 
pressure and 
decreased flow 
 Device restrictions 
RNA from alveolar 
rhabdomyosarcoma cancer 
cells and buccal cells 
[84] 
Genomic DNA from whole 
blood 
[85] 
RNA from influenza A virus 
in a mock nasal swab 
[86] 
Aluminum 
Oxide 
Membranes 
 Does not inhibit 
PCR 
 Not reusable 
DNA from B. cereus cells and 
synthetic HIV RNA gag 
fragments 
[87] 
DNA from methicillin-
susceptible and methicillin-
resistant S. aureus in saliva 
[88] 
Photo-Activated 
Polycarbonate 
Surfaces 
 Less expensive 
 Patterned easily 
 Does not bind 
SPS 
 Disposable 
 Stability of 
activated surface 
over time and 
range of conditions 
Genomic DNA from whole 
blood and RNA from E. coli 
[90, 
92] 
Multiplex DNA isolation from 
B. subtilis, S. aureus, and E. 
coli 
[93] 
Amine-coated 
Surfaces 
 Uses pH instead 
of PCR-inhibiting 
solutions 
 Many ways to 
generate amine 
surfaces 
 Attracts other 
negative species 
 High pH of elution 
buffer could 
inhibit downstream 
processes 
Genomic DNA from whole 
blood 
[94] 
Electrophoretic 
Techniques 
 No need for 
external pumps 
(smaller 
experimental 
setup) 
 Does not use 
PCR-inhibiting 
solutions 
 Insensitive to 
device material 
and dimensions 
 Difficult to 
integrate 
downstream 
processes 
 Electrophoretic 
mobility of NAs 
must be known 
Genomic DNA from whole 
blood via ITP 
[95] 
DNA from P. falciparvum in 
whole blood via ITP 
[96] 
Chromatin from E. coli via 
DEP trapping 
[98] 
RNA from E. coli and S. 
thermophiles via gel-EP 
[99] 
Organic Liquid 
Isolation 
 Well-established 
on macroscale 
 High purification 
efficiency 
 Accommodates 
very small 
samples 
 Uses extremely 
hazardous organic 
solvents 
Multiplex DNA and RNA 
isolation from P. aeruginosa 
and S. aureus 
[101] 
  
 
100% extraction efficiency with complex samples has yet to be realized. Wen et al. demonstrated 
using a protein removal step before NA isolation, which substantially increased the NA extraction 
efficiency.[53] These types of pre-isolation preparation steps can be implemented to improve the 
effectiveness of the device and move toward 100% efficiency. In the technologies reviewed here, 
very few of them were integrated into complete µTAS devices able to handle raw samples and 
take them through to detection. This will be a necessary step toward developing truly point-of-care 
devices that can be used in a variety of places, including resource-limited locations. 
4 Scope of the Thesis 
The work presented in this thesis is based upon the development of new techniques and 
materials that can be implemented into novel biosensors for the purpose of point-of-care 
applications. Firstly, a unique, very simple microfluidic device developed for isolation and 
NASBA-based amplification of mRNA from C. parvum lysate will be presented. This technology 
was developed to simplify the combination of these two techniques and improve upon the existing 
technology in terms of ease-of-use and sensitivity. Secondly, the integration of electrospun 
nanofibers into paper-based lateral flow assays will be discussed. Here, an enzymatic sandwich 
immunoassay was ultimately proven to be successful using functionalized nanofibers, and non-
specific binding was also eliminated using nanofibers incorporating anti-fouling polymeric 
materials. Finally, a summary of the conclusions from the research presented as well as future 
outlooks and next steps will be discussed. 
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CHAPTER 2 
ISOLATION AND AMPLIFICATION OF mRNA WITHIN A MICROFLUIDIC LAB ON A 
CHIP1 
Abstract 
The major modules for realizing molecular biological assays in a micro total analysis 
system (µTAS) were developed for the detection of pathogenic organisms. The specific focus was 
the isolation and amplification of eukaryotic messenger RNA (mRNA) within a simple, single-
channel device for very low RNA concentrations that could then be integrated with detection 
modules. The hsp70 mRNA from Cryptosporidium parvum was used as a model analyte. Important 
points of study were surface chemistries within poly(methyl methacrylate) (PMMA) microfluidic 
channels that enabled specific and sensitive mRNA isolation and amplification reactions for very 
low mRNA concentrations. Optimal conditions were achieved when the channel surface was 
carboxylated via UV/ozone treatment followed by the immobilization of polyamidoamine 
(PAMAM) dendrimers on the surface, thus increasing the immobilization efficiency of the 
thymidine oligonucleotide, oligo(dT)25, and providing a reliable surface for the amplification 
reaction, importantly, without the need for blocking agents. Additional chemical modifications of 
the remaining active surface groups were studied to avoid non-specific capturing of nucleic acids 
and hindering of the mRNA amplification at low RNA concentrations. Amplification of the mRNA 
was accomplished using nucleic acid sequence-based amplification (NASBA), an isothermal, 
primer-dependent technique. Positive controls consisting of previously generated NASBA 
                                                 
1 This section has been reproduced, with modifications to conform to the required format, with permission from 
Analytical Chemistry, in press. Unpublished work copyright 2013 American Chemical Society. S. J. Reinholt, A. 
Behrent, C. Greene, A. Kalfe, A. J. Baeumner, Anal. Chem. 2013, DOI 10.1021/ac403417z. 
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amplicons could be diluted 1015 fold and still result in successful on-chip re-amplification. Finally, 
the successful isolation and amplification of mRNA from as few as 30 C. parvum oocysts was 
demonstrated directly on-chip and compared to bench-top devices. This is the first proof of 
successful mRNA isolation and NASBA-based amplification of mRNA within a simple 
microfluidic device in relevant analytical volumes. 
1 Introduction 
Rapid and reliable detection of microorganisms is essential for useful applications in areas 
such as food safety, water quality, clinical analysis, and defense against bioterrorism. Traditional 
microbiological methods requiring the use of culturing techniques are time-consuming, and only 
applicable to organisms that can be grown under laboratory conditions. For these reasons, when 
possible, they have been replaced by techniques that involve polymerase chain reaction (PCR) 
with real-time detection as these assays are highly specific, highly sensitive, and very rapid 
needing only hours instead of days to produce a conclusive result.[1-5] 
Portability of these assays is also very advantageous and allows for onsite, or point-of-care, 
testing, which further decreases the time and cost of acquiring results. The concept of a micro total 
analysis system (µTAS), later indicated as a lab on a chip, was introduced by Manz et al. in the 
early 1990s.[6,7] They proposed scaling down the size of chemical analytical devices to improve 
performance. An ideal µTAS requires only a small volume of sample and incorporates all 
necessary manipulation and analysis steps to deliver a quantitative, or in some cases qualitative, 
result in a simple sample-in-answer-out fashion. The µTAS concept has also been applied to 
biological assays, including the detection of microorganisms within microfluidic devices, and 
many of these systems have successfully incorporated PCR into the design.[1-5] As the temperature 
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cycling necessary in PCR greatly increases the complexity of devices that incorporate this method 
of amplification, isothermal amplification processes have been explored. Amplification 
techniques, such as helicase-dependent amplification (HDA),[8,9] loop-mediated isothermal 
amplification (LAMP),[10-12] rolling circle amplification (RCA),[13,14] and nucleic acid sequence-
based amplification (NASBA),[15-18] have been integrated into µTAS designs, offering decreased 
chip complexity as there is no need for temperature cycling equipment. NASBA is a primer-
dependent amplification technique that is able to amplify single-stranded RNA.[19] Specifically, 
this process uses T7 RNA polymerase, RNaseH, avian myeloblastosis virus (AMV) reverse 
transcriptase, two primers specific to the target sequence, deoxynucleoside triphosphates (dNTPs), 
and buffers to facilitate a cyclic amplification reaction at a constant temperature that is capable of 
producing a 109-fold amplification in 90-120 minutes.[19] NASBA was the amplification technique 
used in this study. 
Many of these microanalytical systems that incorporate nucleic acid amplification use 
glass-, silicon- and quartz-based devices.[20] However, the fabrication of these microchips is often 
expensive and time-consuming.[20] Consequently, organic polymers have been used as an 
alternative.[3,9,10,15,17,18,21-27] Poly(methyl methacrylate) (PMMA) is a commonly used substrate for 
microfluidic device fabrication due to its advantageous properties, including its machinability, low 
cost, and optical transparency,[20,28] and it was explored as a new material for NASBA in this study.  
Within microfluidic devices, silica structures/beads[15,29-31] and paramagnetic beads[32,33] 
are often used for nucleic acid isolation from a lysate sample. However, these methods require 
increased microdevice complexity, are more complicated to use, and are expensive. Furthermore, 
the previous microdevice that incorporated both nucleic acid isolation and NASBA had separate 
chambers for isolation and NASBA,[15] making the device more complex to fabricate and use as 
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well as increase the potential loss of target nucleic acids during transfer, which is especially a 
problem at low RNA concentrations. Here, we present a very simple single-microchannel design 
that uses surface chemistry to facilitate both the nucleic acid isolation and NASBA. 
The protozoan parasite, Cryptosporidium parvum (C. parvum), is an organism of interest 
in the water quality community due to its highly infective nature in humans and other 
mammals.[34,35] This pathogen causes the disease, cryptosporidiosis, which is a gastrointestinal 
disease that is potentially fatal in immunocompromised and immunosuppressed patients.[34,35] This 
parasite is of concern in countries relying on chlorination as a form of water treatment as it is 
ineffective when C. parvum is in its oocyst state.[34,35] Due to the worldwide importance of C. 
parvum detection, it was chosen as the model analyte for our µTAS. 
In this study, we present a PMMA microfluidic device that is capable of isolating and 
amplifying specific messenger RNA (mRNA) from lysed C. parvum oocyst samples. Specifically, 
mRNA is targeted to differentiate between and only detect viable oocysts, since dead oocysts are 
not infectious.[36] The microchannels undergo surface chemistry modifications to enable mRNA 
isolation directly on the channel surface, and amplification via NASBA is performed within the 
same channel. Surface modifications of the channels were studied to determine an optimal surface 
for both mRNA isolation and amplification, avoid non-specific binding of proteins and nucleic 
acids, and hence prevent loss of NASBA enzymes and increase availability of the mRNA to these 
enzymes. 
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2 Experimental Methods 
2.1 Microfluidic Channel Fabrication 
Microfluidic channels were patterned simply and rapidly in PMMA (Lucite Int., UK) via a 
hot embossing technique using a copper template as previously described.[25] The copper template 
was fabricated at the Cornell Nanoscale Facility (CNF) via photolithography using KMPR 1050 
(Micro-Chem Corp., MA) and copper electroplating resulting in elevated channel structures. A 
5x5cm piece of PMMA was sandwiched between the copper template and a blank copper plate, 
and using a hot press (CarverLaminating), the PMMA was patterned at 130°C and 8000 lbs. of 
pressure for 10 minutes. Inlet and outlet holes were drilled in the embossed piece of PMMA. The 
device was bonded similarly to that previously described using UV/ozone-assisted thermal 
bonding.[37] The embossed PMMA and a second 5x5cm piece of blank PMMA were UV/ozone-
treated for 10 minutes using a UVO-Cleaner (Model 144AX, Jelight Company Inc, Irvine, USA). 
This treatment decreases the glass transition temperature of the surface only, which ensures 
bonding of the channels without channel deformation.[37] They were then sandwiched between two 
blank copper plates, and pressed at 90°C and 5000 lbs. of pressure for 10 minutes. Tygon tubing 
(S-54-HL, Murdock Industrial) with an inner diameter of 0.010” and outer diameter of 0.030” was 
glued at the inlet and outlet holes of the channels to allow connection to 1mL syringes (Becton, 
Dickinson and Company) with 30-gauge, luer lock, blunted, stainless-steel needles (Small Parts, 
Inc.). After fabrication, the chips were stored dry, and typically used the following day. Prior to 
any surface chemistry, nuclease-free water was pumped into the channels by hand at a high flow 
rate to expel all the air and ensure no bubble trapping occurred, as well as to test for leakage. Figure 
2.1 shows a completely assembled microfluidic device consisting of 6 microchannels each with a 
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volume of approximately 3.5µL, as well as a schematic representation of the mRNA isolation and 
NASBA within the microchannels with surface chemistry modifications described below. 
2.2 Surface Chemistry Modification 
The UV/ozone treatment, prior to bonding, chemically modified the surface of the PMMA 
resulting in a carboxylated surface,[38] which facilitated the surface chemistry modifications for 
mRNA isolation. Polyamidoamine (PAMAM) dendrimers (Dendritech Inc.) were immobilized on 
 
 
Figure 2.1: Image of a completed 6-channel microfluidic device and a step-by-step schematic of the 
isolation and NASBA process within the microchannels. A sample of C. parvum lysate with the target 
mRNA (A) flows into the surface-modified microchannel (B), where the mRNA is isolated (C). NASBA 
reagents are injected into the microchannel, and the target mRNA is amplified (D). 
 
the channel surface to ultimately increase the immobilization efficiency of oligomer probes.[39] 
The PAMAM dendrimers used were 5th generation dendrimers, which possess 128 amine surface 
groups, and they were immobilized using 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 
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hydrochloride (EDC)/N-Hydroxysuccinimide (NHS) crosslinking chemistry. This was 
accomplished by flowing 150µL of solution (200mM EDC (Sigma Aldrich), 200mM NHS 
(Thermo Scientific), and 500mM NaCl (Sigma Aldrich) in 50mM 2-(N-
Morpholino)ethanesulfonic acid (MES) (FisherBiotech) pH 6.0) through the channels at 5µL/min 
using a syringe pump (KD Scientific, MA). EDC initially reacts with the carboxylic acid groups 
on the channel surface, and then it is replaced by NHS to form a more stable NHS-ester that readily 
reacts with amine groups. Immediately following the EDC/NHS reaction, 150µL of 2mM 
PAMAM dendrimers in a solution of 10mM NaCl and 50mM N-(2-Hydroxyethyl)piperazine-N'-
2-ethanesulfonic acid (HEPES) (Mallinckrodt Baker) pH 8.5 were pumped through the channels 
at 1µL/min and allowed to incubate at room temperature overnight. The channels were then rinsed 
with 200µL of nuclease-free water (BDH) at 20µL/min. Phosphate-modified thymidine 
oligonucleotides, 5’-[Phos]-[T]25-3’ ([Phos]-oligo(dT)25) (Eurofins MWG Operon) were then 
immobilized on the periphery of the dendrimers using EDC as a crosslinker. Here, 150µL of 
solution (60µM [Phos]-oligo(dT)25, 200mM EDC, and 100mM imidazole (Sigma Aldrich) in 
nuclease-free water) were pumped through the channels at 1µL/min and again allowed to incubate 
overnight at room temperature.  
The remaining unmodified amine groups on the dendrimers were subsequently modified 
to eliminate the positive charges that resulted from the amine groups. Without this modification, 
the amine groups would attract the negatively charged DNA and RNA molecules to the surface 
and render them unavailable to the NASBA enzymes. The unmodified amine groups were 
converted to carboxylic acid groups via succinic anhydride modification. A solution of 200mM 
succinic anhydride (Alfa Aesar) in 700mM borate buffer adjusted to pH 9 was used, and 200μL 
were pumped through the channels at 20μL/min. This was followed by a 200μL wash with 1M 2-
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Amino-2-hydroxymethyl-propane-1,3-diol (Tris)-HCL (Sigma Aldrich) adjusted to pH 9 pumped 
through the channels at 20μL/min. The channels were then rinsed by pumping 200μL of nuclease-
free water at 20μL/min. The microfluidic channels were then ready to be used for C. parvum 
isolation and amplification. 
2.3 Evaluation of Surface Chemistry Modifications 
To evaluate carboxylation density on the channel surface after UV/ozone treatment, an 
assay using Toluidine Blue O (TBO) (TCI America) was performed. TBO is a dye that adsorbs to 
carboxylic groups in an alkaline environment and desorbs in acidic conditions.[40] After bonding 
the channels, 200µL of 500µM TBO in deionized water adjusted to pH 10 were pumped through 
the channels at 20µL/min, which caused the TBO to adsorb. The channels were washed with 
200µL of deionized water adjusted to pH 10 at 20µL/min. Finally, 150µL of 50% (w/w) acetic 
acid were pumped through the channels at 20µL/min to cause desorption of the TBO, and the 
effluent was collected in a 96-well microtiter plate. The absorption at 633 nm was measured using 
a PowerWave XS plate reader (BioTek Instruments Inc.). 
An Acid Orange 7 (AO7) assay[41] was used to assess the density of amine groups, and 
therefore of dendrimers immobilized on the surface of the channels. The assay is analogous to the 
TBO assay described above. A solution of 1mM AO7 (TCI America) in deionized water adjusted 
to pH 3 was pumped into the channels and washed with deionized-water at pH 3. The dye was 
desorbed with deionized water adjusted to pH 12 and collected in a 96-well microtiter plate. Flow 
rates and volumes were the same as described for the TBO assay above. The absorption was 
measured at 460 nm using a plate reader. 
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The immobilization efficiency of oligo(dT)25 on a dendrimer-modified surface was 
compared to that on a simple carboxylated surface by measuring its capture efficiency of a 
fluorescent complimentary adenosine oligonucleotide, oligo(dA)25. For this comparison, amine-
modified oligo(dT)25 probes were immobilized onto the carboxylated microchannel surface (no 
dendrimers) using EDC as a crosslinker, and this was done by pumping the EDC/NHS solution 
through the channels as described above, and then pumping 150µL of 60µM [NH2]-oligo(dT)25 
and 10mM NaCl in 50mM HEPES at pH 8.5 through the channels at 1µl/min and allowing 
incubation overnight at room temperature. Fluorescein-conjugated oligo(dA)25 was prepared at 
10µM in nuclease-free water, and 100µL were pumped through both types of modified channels 
at 5µL/min. The excess oligo(dA)25 was washed out of the channels using 30µL of washing buffer 
B (Invitrogen Dynabeads Kit) at 1µL/min. The channels were placed on a heating block set at 
82°C, 150μL of 0.01M Tris-HCl at pH 7.5 was pumped through the channel at 20μL/min, and the 
effluent from each channel was collected in a 96-well microtiter plate. The fluorescence was 
measured using an FLx800 fluorescence plate reader (BioTek Instruments Inc.) at an absorbance 
wavelength of 485nm and an emission wavelength of 528nm. Carboxylated channels and 
dendrimer-modified channels without oligo(dT)25 were also tested as negative controls. 
2.4 Heat Shock and Lysis 
Live C. parvum oocysts in 1x phosphate-buffered saline (1xPBS) were obtained from 
Waterborne Inc., and diluted to concentrations of interest using nuclease-free water. The oocyst 
samples were heat-shocked in a heating block at 41°C for 5 minutes to cause a high transcription 
yield of the target, heat-shock protein 70 (hsp70) mRNA. The oocysts samples were subsequently 
diluted in Lysis Binding Buffer (Invitrogen Dynabeads Kit) and lysed via five repeated freeze-
thaw cycles. The samples were stored at -80°C until needed.  
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2.5 mRNA Isolation within the Microchannels 
A volume of 150µL of C. parvum lysate was pumped through the channels at 5µL/min. 
This allowed any mRNA in the sample to hybridize with the immobilized oligo(dT)25 via its poly-
adenosine (poly-A) tail. Several different washing techniques were tested to clear the cellular 
debris, proteins, unbound nucleic acids, and lysis binding buffer out of the channels without 
washing out the desired target mRNA. The optimal washing parameters were to pump 100µL of 
washing buffer B (Invitrogen Dynabeads Kit) through the channels at 5µL/min and then 50µL of 
nuclease-free water at 5µL/min. Finishing the washing steps with nuclease-free water is necessary 
as many buffers including the lysis binding buffer and washing buffer B inhibited NASBA. Bench 
top controls for the isolation procedure were performed in Eppendorf tubes (VWR) using 
paramagnetic beads coated with oligo(dT)25 according to the manufacturer’s instruction in the 
Dynabeads® mRNA DIRECT™ Micro Kit (Invitrogen). 
2.6 NASBA within the Microchannels 
The NASBA solution consisting of enzymes, primers, and dNTPs was prepared using the 
NucliSENS Easy-Q Basic Kit (BioMérieux, USA) according to the manufacturer’s instructions. 
The sequences for both primers can be seen in Table 2.1. This solution was pumped into the 
channels by hand until the microchannels were completely filled. The microchannels were then 
submerged in a water bath set at 41°C for 90 minutes with gentle manual agitation every 30 
minutes. Following incubation, the samples were expelled from the channels into Eppendorf tubes 
for off-chip detection. Positive NASBA controls were samples of NASBA amplicon diluted 1:108 
in nuclease-free water. Negative NASBA controls were samples containing only nuclease-free 
water. These controls underwent NASBA on the bench top where the NASBA reagents and 
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enzymes were added directly to the Eppendorf tube and incubated in a water bath at 41°C for 90 
minutes. Controls accounting for cross-reactivity with other microorganisms were perform 
previously,[42] and here, the specificity of the assay to C. parvum was confirmed. 
2.7 Lateral Flow Assay 
A lateral flow assay (LFA) was used to detect any C. parvum target sequences in the sample 
solution.[35] These assays used sulforhodamine B (SRB)-encapsulating liposomes tagged with C. 
parvum reporter probe (Table 2.1) that were synthesized as previously described.[43] A 1µL volume 
of sample solution was mixed with 1µL of liposomes, 1µL of 1x HEPES sucrose saline (1xHSS), 
and 5µL of hybridization buffer (20% formamide, 4x saline sodium citrate (4XSSC), 0.2% Ficoll 
type 400, and 125mM sucrose), and this solution was incubated at 41°C for 5 minutes to allow any 
target sequences to hybridize with the reporter probes conjugated to the liposomes. These samples 
were allowed to vertically flow up nitrocellulose strips containing immobilized C. parvum capture 
probes (Table 2.1). Samples containing target sequences formed sandwich hybridizations that 
produced a colorimetric signal. The LFA signals were evaluated visually and scanned using a 
flatbed scanner. ImageJ software was then used for quantification of the obtained signal intensities. 
This approach was chosen over analyses via a reflectometer[44] as the probing surface would not 
have covered the entire strip surface in the latter approach. 
Table 2.1: C. parvum-associated Sequences[42] 
DNA Probe/Primer Sequence 5’-3’ 
NASBA Primer 1 
AATTCTAATACGACTCACTATAGGGAGAAGGTAGAACCACC
AACCAATACA 
NASBA Primer 2 AGATTCGAAGAACTCTGCGCTGA 
Reporter Probe GTGCAACTTTAGCTCCAGTT 
Capture Probe AGATTCGAACTCTGCGC 
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The entire assay for C. parvum detection takes approximately 3 hours from heat shock to 
colorimetric signal detection via lateral flow assay. 
3 Results and Discussion  
The ultimate goal of the presented studies was to combine isolation and amplification of 
mRNA molecules into a single inexpensive, simple, polymer-based microfluidic device. 
Previously, there has only been one demonstration of nucleic acid isolation and NASBA within 
the same microchip[15] to our knowledge, and here, solid-phase extraction via silica beads was used 
for nucleic acid isolation. This nucleic acid isolation technique increases chip complexity, 
decreases ease of use, and non-specifically binds all nucleic acids using chaotropic salts and 
organic solvents that inhibit NASBA. Thus, an exploration of surface modifications within the 
microfluidic channels to facilitate mRNA isolation was performed to realize an efficient capture 
method while avoiding non-specific binding and denaturing of NASBA enzymes. 
3.1 Microfluidic Channel Fabrication 
The use of PMMA as the substrate material has several advantages. PMMA is inexpensive, 
durable, very easy and inexpensive to pattern, and easily facilitates the surface chemistry for 
mRNA isolation. Our extremely simple single-channel design is also very beneficial. Unlike the 
previous design that contained separate chambers for nucleic acid isolation and amplification, our 
design enables simple fabrication and operation as well as the elimination of losses due to nucleic 
acid transfer between the isolation and amplification modules, which is especially critical for low 
RNA concentrations. Additionally, each chip contains six parallel microchannels that enable six 
samples to be processed in parallel on a single chip demonstrating the ability for multiplexing with 
our design. 
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3.2 Surface Chemistry Modification 
In order to render the PMMA surface chemically active, carboxylic acid groups were 
generated using UV/ozone treatment, which were subsequently changed to amine groups using 
PAMAM dendrimers. The density of carboxylic acid groups after UV/ozone treatment and amine 
groups after dendrimer immobilization on the surface of the channel was measured using simple 
dye assays for an initial assessment of the success of the modification. TBO assays determined the 
carboxylic acid density to be between 5 and 33 nmol/cm², with a relative standard deviation (RSD) 
up to 33%. AO7 assays were used to measure the amine-group density after channels were coated 
with PAMAM dendrimers and values between 70 and 105 nmol/cm² were obtained. The RSD was 
between 3 and 26% for channels within the same experiment, and 20% between experiments. 
While being simple methods, they provided a reasonable and rapid indication of the desired surface 
modifications, which were then further used and more quantitatively analyzed as described below. 
Most importantly, it was determined that the use of PAMAM dendrimers provides a significant 
increase in the number of available functional group as compared to simple UV/ozone 
functionalization alone. 
The advantage of using a dendrimer surface was then quantitatively demonstrated by 
testing the immobilization efficiency of oligo(dT)25 and the capture efficiency of oligo(dA)25 by 
immobilized oligo(dT)25 on both the carboxylated channel surface and dendrimer-modified 
channel surface (Figure 2.2). The concentration of oligo(dT)25 on the channel surfaces was 
quantified using fluorescently-labelled oligonucleotides. Here, an 18-fold increase in the number 
of immobilized oligo(dT)25 molecules was found using a dendrimer-modified surface versus a 
simply carboxylated surface (Figure 2.2a). This dramatic difference was still apparent when 
evaluating the actual hybridization functionality of the immobilized oligonucleotides. Here, 
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fluorescently-labelled oligo(dA)25 was allowed to hybridize with the immobilized oligo(dT)25 
capture probes. The dendrimer-modified surface resulted in a 16-fold increase in capture efficiency 
relative to the carboxylated surface (Figure 2.2b). Consequently, all of the channels used for 
mRNA isolation had dendrimer-modified surfaces. 
In previous reports of microfluidic NASBA, blocking of the device surface using BSA or 
yeast tRNA was necessary to prevent non-specific adsorption of the NASBA enzymes.[15-18] This 
requires additional steps, which can increase the overall assay time, or if added to the NASBA 
mixture can present potential interferents, which can affect NASBA. However, blocking agents 
are not necessary in the device presented here; the surface modifications necessary for efficient 
and simple mRNA isolation provide a suitable surface for NASBA, making it therefore a 
significantly more robust device. 
3.3 mRNA Isolation within the Microchannels 
Initially, isolation of the mRNA from lysed C. parvum oocyst samples within the 
functionalized channels was demonstrated independently from an on-chip NASBA reaction. Here, 
following the on-chip mRNA isolation procedure, the captured mRNA was dehybridized and 
expelled from the channels into Eppendorf tubes by pumping 20µL of nuclease-free water at 
20µL/min while the channels were submerged in a water bath at 65°C. The NASBA reaction 
solution was then added to each tube and they were incubated in a water bath at 41°C for 90 
minutes following conditions previously published for C. parvum hsp70 mRNA.[45] It was quickly 
determined that only the surfaces containing the dendrimers enabled a truly reliable and successful 
mRNA isolation. While some success was also obtained with carboxylated surfaces, the 
dendrimer-modified surface proved to be more reliable for both mRNA isolation and amplification 
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Figure 2.2: Comparison of oligo(dT)25 immobilization efficiency and oligo(dA)25 capture efficiency by 
oligo(dT)25 on carboxylated channel surfaces and dendrimer-modified channel surfaces. Fluroescently-
labelled oligo(dT)25 was immobilized on carboxylated surfaces containing no dendrimers and dendrimer-
modified surfaces, and the fluorescence intensities were compared for the different surfaces (A). 
Fluorescently-labelled oligo(dA)25 (complimentary target) was captured on both carboxylated and 
dendrimer-modified surfaces with immobilized oligo(dT)25 capture probes, and the fluorescence was 
quantified (B: blue bars). Fluorescent oligo(dT)25 (non-complimentary target) was also pumped through 
both of these channels to determine the non-specific binding to each type of surface (B: red bars). 
 
within the same channel.  Here, when challenging the procedure to low analyte concentrations, 
successful mRNA isolation could be demonstrated for as few as 10 and 50 oocysts (Figure 2.3). 
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Signals obtained are lower than that of the positive control (a 1:108 dilution of positive NASBA 
amplicon) as a low mRNA concentration is to be expected from 10 and 50 oocysts, since the RNA 
was highly diluted when expelled from the microfluidic channel (into a 20µL, instead of 5µL, 
volume) and because we assume that isolation and dehybridization reactions did not provide a 
100% yield. 
 
Figure 2.3: Results from mRNA isolation within the microchannels and bench top NASBA. The results of 
on-chip isolation and off-chip NASBA for 10 and 50 C. parvum oocysts are shown by the LFA strips (A). 
An ImageJ quantification of the color intensity of the strips is also shown (B). The positive control is 
NASBA amplicon diluted by 108.   
 
3.4 NASBA within the Microchannels 
Secondly, NASBA was realized within the microchannels separately from mRNA isolation 
from lysed oocysts. Initially, a set-up was determined that would result in a temperature-controlled 
environment to ensure appropriate NASBA conditions. While ultimately an internal heating 
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element will be desirable, a water bath was chosen to avoid temperature fluctuations and facilitate 
easy access to the microfluidic channel for desired manipulations. The seal achieved through the 
device fabrication ensured a no-leakage set up. Samples chosen initially were dilutions of NASBA 
amplicons. In the bench top positive control, the amplicon is diluted by a factor of 108. For 
assessing NASBA within the channels, dilutions of 1010, 1011, 1013, and 1015 were tested. These 
samples were mixed with the NASBA reaction solution and pumped into the channels. The 
channels were then incubated at 41°C for 90 minutes with gentle agitation every 30 minutes. Initial 
experiments were carried out in microfluidic channels with varying surface chemistries including 
carboxylic acid groups, dendrimers (amine groups), as well as dendrimer surfaces blocked with 
0.01-1% (w/v) polyvinyl pyrrolidone, 0.1-1% (w/v) bovine serum albumin (BSA), 0.01-1% (w/v) 
gelatin, and 1.11-111ng of extracted Escherichia coli (E. coli) RNA. However, in all of these cases 
only insufficient or unreliable amplification was observed. It was assumed that enzyme adsorption 
to the channels and/or loss of mRNA through non-specific binding led to unsuccessful 
amplification reactions.  
General protein adsorption to the channel surface (and possibly Tygon tubing) was 
therefore determined through a model protein, horseradish peroxidase (HRP). Here, a 0.1µg/mL 
concentration of HRP was pumped through the microfluidic channel and the activity was 
determined in the outflow. However, the possible loss that may have occurred in the channels 
could not be differentiated from the original solution. It was therefore assumed that inaccessibility 
of mRNA molecules for NASBA amplification was likely the main challenge. Thus, the 
dendrimers’ peripheral amine groups were modified using succinic anhydride to convert the amine 
groups to carboxylic acid groups. This provided repelling surfaces for mRNA molecules and 
assisted in achieving an appropriate pH of approximately 8.5 for the NASBA reaction. When 
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utilizing this optimized dendrimer surface coupled to oligo(dT)25 capture probes, highly reliable 
and sensitive amplification could be realized (Figure 2.4). The dilution of the positive NASBA 
amplicon to 1015 is pushing the limit of RNA molecules present in a sample as NASBA typically 
provides a 109 – 1011-fold amplification of RNA molecules.[46] Thus, on-chip NASBA was 
demonstrated to be highly successful and could now be combined with on-chip mRNA isolation.  
 
 
Figure 2.4: Results from NASBA within microchannels using diluted amplicon. The results of on-chip 
NASBA for amplicon dilutions of 1010-1015 are shown by the LFA strips (A). An ImageJ quantification of 
the color intensity of the strips is also shown (B). The negative control is a sample of nuclease-free water 
(no amplicon) that underwent NASBA. 
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3.5 mRNA Isolation and NASBA within the Microchannels 
Finally, on-chip isolation of hsp70 mRNA from lysed C. parvum oocyst samples with 
subsequent on-chip NASBA was successfully demonstrated in the functionalized microfluidic 
channels within the same device. Various assay conditions were investigated including different 
washing volumes, flow rates, and buffers. It was found that these factors highly influenced the 
reliability of the on-chip isolation and NASBA reaction once the dendrimer-oligo(dT)25 surface 
was optimized. Chaotropic salts and organic compounds in the lysis buffer and washing buffer 
needed to be removed from the microfluidic channels prior to realizing a successful NASBA 
reaction. At the same time, captured mRNA needed to remain hybridized on the dendrimer-
oligo(dT)25 surface and accessible for NASBA enzymes and primer binding. In the end, the most 
reproducible results were obtained by washing with 100µL of washing buffer B at 5µL/min, and 
then 50µL of nuclease-free water at 5µL/min.  On-chip isolation and on-chip amplification of 
mRNA from just 30 oocysts was successfully demonstrated (Figure 2.5). These results are a 
significant improvement over the limit of detection reported in the previous microfluidic device 
incorporating nucleic acid isolation and NASBA, where detection of 100 Escherichia coli cells 
was reported.[15] This suggests an increased performance using surface modifications for nucleic 
acid purifications over solid-phase isolation as well as a single isolation and amplification chamber 
to eliminate nucleic acid losses during transport to the amplification chamber. In fact, we have 
determined that isolation and amplification of higher concentrations of cells (data not shown) 
demands less defined surface conditions, and leads to easier success, although working at very low 
RNA (and cell) concentrations requires additional attention. In addition, the dendrimer surface 
provided a highly reliable surface for avoiding false negative results. 
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Figure 2.5: Results from mRNA isolation and NASBA within the microfluidic channels. The results of on-
chip mRNA isolation and NASBA for C. parvum lysate are shown by the LFA strips (A). An ImageJ 
quantification of the color intensity of the strips is also shown (B). The negative control for NASBA is a 
sample of nuclease-free water. 
 
4 Conclusion 
 In biological and chemical analysis, µTASs are increasingly becoming the end goal of 
developing assays for on-site and point-of-care use. The portability and simplicity of these devices 
is crucial if they are to be used in resource-limited areas and in situations where experts are not 
readily available. In this study, we have presented a simple PMMA-based microfluidic device that 
can isolate and amplify C. parvum mRNA from lysed oocysts through surface chemistry 
modifications and NASBA within the same channel. By incorporating PAMAM dendrimers, a 
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significant increase in the immobilization efficiency of the oligo(dT)25 capture probe was achieved, 
which provided a 16-fold increase in its capture efficiency. The resulting surface also provided a 
suitable surface for amplification without necessitating the use of blocking reagents that have 
always been needed with past on-chip NASBA reactions. Through the exploration of different 
washing regimes, 30 C. parvum oocysts were successfully detected, and this represents a 
significant improvement in detection compared to the previous device incorporating nucleic acid 
isolation and NASBA. The isolation and amplification steps of the assay are very important and 
will be central to a complete µTAS for C. parvum oocyst detection, which will also incorporate 
previously developed oocyst lysis (Rheonix Inc.)[47] and electrochemical detection[48] steps. The 
presented device is envisioned to be a functional module in a µTAS integrating immunomagnetic 
separation[42] upstream and electrochemical detection[48] downstream of the module. It is therefore 
designed to be a highly portable device that is inexpensive, due to the materials ($0.22 in material 
cost) and fabrication methods used, as well as easy to use, due to the designed simplicity of the 
assay. An example integration of this device is the automated liquid-handling system, such as the 
fluidic CARDTM platform developed by Rheonix Inc.[47] The proposed system can be used to detect 
any eukaryotic microorganism through the mRNA isolation mechanism. This is the first 
demonstration of C. parvum mRNA isolation and amplification using NASBA within a very 
simple microfluidic device. While being a relevant analyte in itself, C. parvum is a prime example 
of a difficult biological analyte that can be detected with high sensitivity in chip-based devices. 
The combination of isolation and amplification into the same microfluidic channel avoids loss and 
contamination otherwise obtained in multi-step procedures, and therefore has the potential as an 
alternative in the bioanalysis of low-concentration analytes.  
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CHAPTER 3 
DEVELOPING NEW MATERIALS FOR PAPER-BASED DIAGNOSTICS USING 
ELECTROSPUN NANOFIBERS2 
Abstract 
The use of electrospun nanofibers as functional material in paper-based lateral flow assays 
(LFAs) was studied. Specific chemical features of the nanofibers were achieved by doping the 
base polymer, poly(lactic acid) (PLA), with poly(ethylene glycol) (PEG) and polystyrene8K-block-
poly(ethylene-ran-butylene)25K-block-polyisoprene10K-Brij76 (K3-Brij76) (KB). The LFAs were 
assembled such that the sample flowed through the nanofiber mat via capillary action. Initial 
investigations focused on the sustainable spinning and assembly of different polymer structures to 
allow the LFA format. Here, it was found that the base polymer poly(vinyl alcohol) (PVA), which 
had shown to function well in microfluidic biosensors, did not work in the LFA format. In contrast, 
PLA-based nanofibers enabled easy assembly. Three relevant features were chosen to study 
nanofiber-based functionalities in the LFA format: adsorption of antibodies, quantification of 
results, and non-specific binding. In particular, streptavidin-conjugated sulforhodamine B (SRB)-
encapsulating liposomes were captured by anti-streptavidin antibodies adsorbed on the nanofibers. 
Varying the functional polymer concentration within the PLA base enabled the creation of distinct 
capture zones. Also, a sandwich assay for the detection of Escherichia coli (E. coli) O157:H7 was 
developed using anti-E. coli antibodies as capture and reporter species with horseradish peroxidase 
for signal generation. A dose-response curve for E. coli with a detection limit of 1.9x104 cells was 
                                                 
2 This section has been reproduced with permission from Springer: S. J. Reinholt, A. Sonnenfeldt, A. Naik, M. W. 
Frey, A. J. Baeumner, Anal. Bioanal. Chem. 2013, DOI 10.1007/s00216-013-7372-5 with modifications to conform 
to the required format. 
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achieved. Finally, functional polymers were used to demonstrate that non-specific binding can be 
eliminated using anti-fouling block copolymers. The enhancement of paper-based devices using 
functionalized nanofibers provides the opportunity to develop a broad spectrum of sensitive and 
specific bioassays with significant advantages over their traditional counterparts. 
1 Introduction 
The emerging field of paper-based microfluidic technology continues to gain great interest 
for the development of point-of-care assays. The complexity of these devices varies widely from 
basic dipsticks and lateral flow assays (LFAs) that have existed since the 1950s[1] to complex two- 
and three-dimensional microfluidic paper analytical devices (µPADs) recently pioneered by the 
Whitesides group.[2-6] There are many advantages to using a paper-based platform for producing 
point-of-care devices for use in resource-limited settings. Fabricating these devices out of paper 
makes them inexpensive, small, portable, and easily disposable.[2,4] These devices are also very 
easy to use and require no external equipment or power source due to their capillary wicking 
capability.[2,4]  
There are a variety of materials used to construct these paper-based networks, and the type 
of paper selected depends on the specific characteristics required for device fabrication and 
operation. The paper materials used most commonly are cellulose fiber-based, which are 
biocompatible and can be chemically modified.[4,7,8] Laboratory filter and chromatography papers, 
such as those manufactured by Whatman, are often chosen as they are made from pure cellulose, 
are free of contaminants, and have a uniform pore size and thickness for uniform wicking.[4,8,9] 
Other papers used for these devices include hydrophobic and hydrophilic nitrocellulose, glossy 
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paper, and cellulose fiber matrices with a variety of different chemical modifications to alter their 
properties.[7-9]  
Generally, the most important properties of the paper when fabricating paper-based devices 
for biological assays are pore size/wicking speed, surface area-to-volume ratio, and its chemical 
nature leading to functionalization, non-specific reactions and modifications for wicking speeds. 
An interesting and novel material in which these properties are all theoretically controllable is a 
mat made of electrospun nanofibers.[10-12] 
Electrospinning is a process in which nanoscale fibers are produced using electrostatic forces 
generated between a charged polymer spinning solution and a grounded collector plate. The 
spinning solution is fed through a needle at a constant rate and a high voltage is applied between 
the needle and collector plate. This causes a Taylor cone to form at the tip of the needle.  When a 
certain threshold voltage is reached, the electrostatic forces become greater than the surface 
tension, and a thin fiber is accelerated toward the collector plate forming an unwoven nanofiber 
mat. This process produces fibers with diameters between a few nanometers and a few 
micrometers.[12] The properties of the nanofiber mats can be controlled by changing the 
electrospinning parameters. Pore size and surface area-to-volume ratio scale with the diameter of 
the nanofibers.[10] The diameter of the nanofibers can be adjusted by altering the feed rate and 
polymer concentration of the spinning solution,[10-12] and to a lesser extent the applied voltage and 
distance between the needle and collector plate.[10] The chemical characteristics of the nanofiber 
surface can be changed by using different types of polymers and combinations of polymers in 
different ratios. Cho et al. created positive and negative nanofibers by electrospinning poly(vinyl 
alcohol) (PVA) nanofibers with hexadimethrine bromide (Polybrene) and poly(methyl vinyl ether-
alt-maleic anhydride) (poly(MVE/MA)), respectively.[13] Tamura and Kawakami produced 
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electrospun nanofibers that had both hydrophobic and hydrophilic domains within the same 
nanofiber by using the block copolymer, NTDA-BDSA-r-APP.[14] The properties of the nanofiber 
mat can thus be catered to the specific application in which it will be used. 
In this study, we investigate the use of poly(lactic acid) (PLA)-based electrospun nanofibers 
in an LFA format to determine the feasibility of incorporating nanofibers into paper-based devices 
and using nanofibers as a platform for paper-based biological assays. The surface properties of the 
PLA nanofibers were adjusted by adding additional polymers to the spinning solution: 
poly(ethylene glycol) (PEG) to increase the hydrophilicity and polystyrene8K-block-poly(ethylene-
ran-butylene)25K-block-polyisoprene10K-Brij76 (K3-Brij76) (KB) to eliminate non-specific 
binding of biological species. Immobilization of antibodies through simple adsorption to the 
nanofibers was also demonstrated and utilized to develop biological assays in an LFA format.  
2 Methods 
2.1 Electrospinning 
PLA nanofiber mats were electrospun as previously described.[15] In our experiments, a 
different gauge of needle was used and the collector plate was at a different distance from the 
spinning needle tip. Briefly, a spinning solution of 22wt% PLA (Jamplast 4043D) in 
dimethylformamide (DMF) (Sigma Aldrich) was prepared at 70°C using a heated stir plate (VWR) 
for 90 minutes. The spinning solution was loaded into a 5mL glass syringe (Cadence Science), and 
a 20-gauge deflected-point needle (Cadence Science) was used. The solution was pumped from 
the syringe at a rate of 10µL/min using a programmable syringe pump (Harvard Apparatus). The 
syringe and needle were heated to 70°C during the spinning process using a heating element and 
VariTemp Blower, respectively. A 15kV voltage was applied to the needle relative to the 4x4cm 
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grounded collector plate positioned 10cm from the tip of the needle, and the nanofibers were spun 
for 30 minutes. To produce PLA-PEG nanofibers, 3wt% PEG was added to the 22wt% PLA 
spinning dope, and the same spinning conditions were applied. 
The triblock terpolymer, polystyrene8K-block-poly(ethylene-ran-butylene)25K-block-
polyisoprene10K-Brij76 (K3-Brij76) (KB), is an amphiphilic polymer that was previously 
synthesized to produce nanofibers with anti-fouling properties.[16] A polymer spinning dope 
solution of 40/60wt% PLA (Jamplast 6201D)/KB in 3:1 v/v chloroform/acetone (Sigma Aldrich) 
was used to synthesize these nanofibers. The nanofibers were spun using a flow rate of 
0.03mL/min and a voltage of 17kV. 
2.2 Assembly of LFAs and Signal Recording 
A simple setup was used to assemble the LFAs incorporating nanofibers. A nanofiber mat 
(4.5x150mm or 1.75x5mm) was adhered directly to a backing card (Millenia Diagnostics) 4.5mm 
in width, so the nanofiber mat remained fixed during sample flow. The backing cards are sheets of 
polyvinyl chloride (PVC) plastic with an adhesive layer, so the sample will not flow into the 
backing cards. An absorbent pad (Millipore) 10x120mm was placed on the backing card such that 
it overlapped with the nanofiber mat by approximately 2mm. The absorbent pad facilitates 
capillary flow of the sample through the nanofiber matrix. Figure 3.1 shows a schematic of the 
simple LFA setup, as well as a schematic of the sandwich binding assay. The assembly of each 
LFA took approximately 1 minute. For each assay described, the signal was colorimetric. An 
image of the LFAs was taken, and the image was analyzed using ImageJ software to quantify the 
color intensity. These intensities were always compared to several negative controls. 
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Figure 3.1: Schematic of LFA format and sandwich binding assay. A 1.75x5mm nanofiber mat was placed 
directly on a backing card 4.5mm in width, and a 1x20cm absorbent pad was placed on the backing card 
overlapping the nanofiber mat by approximately 2mm (a). The LFAs ran vertically in glass culture tubes. 
In the E. coli sandwich assay, E. coli (green) flowed through the anti-E. coli-modified nanofiber mat, 
followed by horseradish peroxidase (HRP)-conjugated (pink) anti-E. coli. When E. coli is present, a 
colorimetric signal results upon addition of HRP substrate (b), and when no E. coli is present, the HRP 
antibodies flow through the nanofiber mat and no signal is observed (c). 
 
2.3 Single-Step Binding Assay 
PLA and PLA-PEG nanofiber mats were used in the LFA configuration described above 
to facilitate a single-step binding assay. In this colorimetric assay, anti-streptavidin antibodies 
(VWR SP-4000) were used to capture streptavidin-conjugated sulforhodamine B (SRB)-
encapsulating liposomes, which were synthesized as previously described by our group.[17] The 
nanofiber mats were prewet with a solution of 5% methanol in 1x 2-Amino-2-hydroxymethyl-
propane-1,3-diol (Tris)-Buffered Saline (1xTBS) to increase the hydrophilicity of the nanofibers 
allowing solutions to wick through the mat more efficiently via capillary action. The nanofibers 
were submerged in this solution for approximately 10 minutes, and then the nanofiber mats were 
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placed in a vacuum oven to dry for 60 minutes at 40°C and 15 in. Hg. The nanofiber mats were 
cut to 4.5x150mm and adhered to the backing card as described above. A 500µg/mL anti-
streptavidin antibody solution in 0.4M NaHCO3/Na2CO3 pH 9 was prepared, and 1µL of this 
solution was pipetted onto each nanofiber mat. The samples were dried in a vacuum oven for 90 
minutes at 40°C and 15 in. Hg. The nanofiber mats were then blocked with a solution of 0.1% 
polysorbate 20 (Tween-20), 0.1% Na-casein, and 0.25% sucrose for 5 minutes. The samples were 
subsequently dried in a vacuum oven overnight at room temperature and 15 in. Hg. 
A 1mM solution of streptavidin-conjugated SRB-encapsulating liposomes in 1x 2-[4-(2-
hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES)-sucrose-saline (1xHSS) was prepared. 
A 3µL volume of liposome solution was pipetted into 12x75mm glass culture tubes (VWR), and 
the nanofiber LFAs were placed vertically into the culture tubes such that the end of the nanofiber 
mat was in contact with the liposome solution and the solution wicked up. Unbound liposomes 
were washed away in the same fashion using 60µL of 1xHSS in a fresh culture tube. A 
nitrocellulose control was performed in the same manner as the nanofiber assays. Negative 
controls contained no anti-streptavidin antibodies. Another negative control for the PLA-PEG 
nanofibers was to use liposomes without streptavidin on their surface to determine whether any 
non-specific binding to the antibody-coated nanofibers occurred. 
2.4 E. coli Sandwich Assay 
To prepare an Escherichia coli (E. coli) O157:H7 liquid culture, a 2wt% aqueous solution 
of LB broth (Fisher Scientific) was prepared and autoclaved, and 5mL was added to a culture tube. 
This solution was inoculated with E. coli O157:H7 and placed in a shaking incubator at 37°C and 
220 rpm for 24 hours.  
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PLA-PEG nanofibers were used for this assay. The nanofibers were prewet as before with 
a 5% methanol solution in 1xTBS, and dried in a vacuum oven at 40°C and 15 in. Hg for 60 
minutes. The nanofibers were cut into 1.75x5 mm mats and the LFAs were assembled as described 
above. A 1mg/mL anti-E. coli capture antibody (Abcam ab20976) solution in 0.4M 
NaHCO3/Na2CO3 pH 9 was prepared, and 0.5µL of this solution was pipetted onto each nanofiber 
mat. The samples were dried in a vacuum oven for 90 minutes at 40°C and 15 in. Hg. The nanofiber 
mats were then blocked with a solution of 2% bovine serum albumin (BSA), 0.1% polysorbate 20 
(Tween-20), 0.1% Na-casein, and 0.25% sucrose for 30 minutes. Next, the samples were dried in 
a vacuum oven overnight at room temperature and 15 in. Hg.  
The concentration of the liquid E. coli culture was determined by measuring the optical 
density at a 600nm wavelength, and the E. coli was diluted to the desired concentration in LB 
broth. A volume of 5µL of E. coli solution was pipetted into glass culture tubes, and the LFAs 
were placed into the culture tubes vertically, so only the edge of the nanofiber mat was in contact 
with the solution. The solution was allowed to wick up completely, and then the nanofibers were 
washed in the same vertical fashion using 60µL of 1xHSS in a new culture tube. A 500µg/mL 
solution of horseradish peroxidase (HRP)-conjugated anti-E. coli reporter antibodies (Abcam 
ab20425) in 1x phosphate-buffered saline (1xPBS) was prepared and 1µL of this solution was 
pipetted onto the bottom edge of the nanofiber mat and allowed to flow through the mat 
horizontally. Excess reporter antibody was washed out of the nanofiber mat vertically using 240µL 
of 1xHSS. After washing, the absorbent pad was removed from the LFA to prevent flow, and 7µL 
of the HRP substrate, 1-Step 2,2'-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium 
salt (ABTS) (Thermo Scientific), was pipetted onto the whole nanofiber mat. The colorimetric 
substrate reaction was allowed to continue for 10 minutes, and a blue-green color resulted. Two 
   75 
types of negative controls were used in this assay. The first omitted both the capture antibody and 
the E. coli cells to test the efficacy of the final wash step. The second negative control was an LFA 
without capture antibody that tested how well the unbound E. coli cells washed out of the 
nanofibers. A schematic representation of this assay is shown in Figure 3.1b and 3.1c. 
2.5 Nanofibers for Eliminating Non-Specific Binding 
The PLA-KB nanofiber mats were prewet for 10 minutes with a solution of 5% methanol in 
1xTBS, and dried in a vacuum oven for 60 minutes at 40°C and 15 in. Hg. The nanofibers were 
cut into 1.75x5mm mats and assembled into the LFA format described above. A 1mM solution of 
carboxylated SRB-encapsulating liposomes was prepared, and 5µL were allowed to wick up the 
nanofiber mat vertically within a glass culture tube. The unbound liposomes were then washed out 
of the nanofiber mat vertically using 60µL of 1xHSS.  The nanofiber mats were imaged with a 
fluorescence microscope to observe any non-specific liposome binding that occurred. These 
nanofibers were compared to PLA nanofibers that had been prewet, were either blocked or 
unblocked, and underwent the same testing process. 
3 Results and Discussion 
Previously, our lab demonstrated that PVA-polybrene nanofibers within a microfluidic 
channel can capture carboxylated SRB-encapsulating liposomes electrostatically, and release them 
upon an increase in pH.[18] The attempt to incorporate this attractive feature into a paper-based 
assay; however, was unsuccessful as the mechanical properties of the nanofibers were unfavorable 
for assembly in an LFA format for both external manipulations and wicking actions. While thicker 
mats overcame some of these challenges, the resulting denser mat made fluid flow difficult. In 
contrast, PLA functioned very well as the nanofiber base polymer. An important characteristic of 
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LFA material is the achievable wicking rate as it directly influences contact time between 
biological assay components. The wicking rate of the nanofibers can be adjusted by changing the 
pore size of the spun mat. In the experiments described below, the wicking rates varied slightly 
due to minimal differences in thicknesses and pore sizes. These differences were caused by varying 
atmospheric conditions during spinning. More reproducible nanofiber mats could be spun given a 
temperature- and humidity-controlled chamber. Nonetheless, highly reproducible wicking rates 
and functionalities were obtained when comparing different nanofiber mats. During an assay, the 
wicking rate changed as the solution wicked into the absorbent pad. The wicking rate slowly 
decreased as the absorbent pad became increasingly saturated, which occurs in any LFA based on 
porous material. The wicking rate on average was 5uL/min. 
3.1 Single-Step Binding Assay 
The ability to incorporate electrospun nanofibers successfully into an LFA was assessed 
using a simple single-step binding assay. Initially, 22wt% PLA nanofibers were spun and the mat 
was used in an assay that involved immobilizing anti-streptavidin antibodies via adsorption onto 
the nanofiber mat and capturing the streptavidin-conjugated SRB-encapsulating liposomes that 
flowed through the mat. Figure 3.2a and 3.2b show scanning electron microscopy (SEM) images 
of the 22wt% PLA nanofibers at two different magnifications. The quality of the assay results was 
promising (see further below). As PLA mats were hydrophobic, varying concentrations of PEG 
were added to the spinning solution, and a final concentration of 3wt% PEG was chosen for the 
22wt% PLA nanofibers. Figure 3.2c shows an SEM image of the 22wt%/3wt% PLA/PEG 
nanofibers. Figure 3.2d shows a fluorescent confocal microscopy image of the PLA-PEG 
nanofibers where the green color represents the natural fluorescence of PEG. Since PEG is 
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hydrophilic, it phase separates preferentially to the outer surface of the PLA nanofibers as was also 
shown by Hendrick and Frey.[19] 
 
Figure 3.2: Microscopic Images of PLA and PLA-PEG Nanofibers. SEM images of 22wt% PLA nanofibers 
at different magnifications (a and b) and an SEM image of 22wt% PLA-3%wt% PEG (c) were taken. A 
confocal microscope image of 22wt% PLA-3%wt% PEG is shown in where the natural fluorescence of 
PEG shows that the PEG is on the periphery of the nanofibers (d). 
 
After assembly of the nanofiber LFAs, 1µL of the 500µg/mL anti-streptavidin antibody 
solution was pipetted onto the nanofiber mats. The size and shape of the capture area containing 
the immobilized antibodies was dependent on the hydrophobicity and thickness of the nanofiber 
mat. The PLA nanofibers produced the widest dispersion of the antibodies and the adsorption area 
was irregularly shaped. This is potentially due the hydrophobicity of the nanofibers as the droplet 
of antibody solution wicked across the surface of the nanofiber mat as opposed to penetrating down 
into the mat, and the irregular shape was the solution wicking through the paths of least resistance. 
The PLA-PEG nanofibers showed less dispersion of the antibody droplet, but still gave an irregular 
shape. In this case the solution wicked down into the full thickness of the nanofiber mat; however, 
there was still excess solution that wicked along the length of the nanofiber mat following paths 
a 
b 
c 
d 
10µm 
10µm 
3µm 22µm 
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of least resistance. To improve the shape of the capture zone, and therefore the appearance of the 
results, a thicker PLA-PEG nanofiber mat was electrospun and tested. A thicker mat decreased the 
amount of spreading observed and a circular capture zone was achieved. Images of the different 
nanofiber mats are inset in Figure 3.3 where PLA-PEG 1 is a thinner mat compared to PLA-PEG 
2. Nitrocellulose controls were performed and circular capture zones were also achieved in this 
case, although the PLA-PEG was better at producing sharper edges.  
A volume of 3µL of 1mM streptavidin-conjugated SRB-encapsulating liposomes were 
allowed to flow through the LFAs after the antibodies were immobilized, and the unbound 
liposomes were washed out using 60µL of 1xHSS. The colorimetric results were quantified using 
ImageJ software. The results for the different nanofiber mats as well as the nitrocellulose control 
are displayed in Figure 3.3. The results show that on average, the thicker PLA-PEG nanofiber mat 
elicits a more intense signal than the PLA and thinner PLA-PEG nanofibers. It should also be noted 
that the signal is comparable to the nitrocellulose control. In all cases, non-specific binding as 
shown by the negative controls, was negligible, with the PLA-PEG mat again outperforming the 
plain PLA mat. Also, here, the PLA-PEG mats performed comparably with the nitrocellulose 
membranes, which is an important initial characteristic needed to then add further capabilities into 
the nanofiber mats that cannot be achieved in standard nitrocellulose designs. Similarly, non-
specific binding of liposomes (without streptavidin), which can occur in nitrocellulose settings,[20] 
was shown to be negligible for the PLA-PEG mats (“C” in Figure 3.3). With the single-step assay 
successfully demonstrated and an appropriate nanofiber mat selected, a sandwich assay using a 
bacteria of interest, pathogenic E. coli O157:H7, was developed using a different signal 
amplification system to further study the general applicability of nanofiber mats in an LFA format. 
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Figure 3.3: Signal comparison of the anti-streptavidin antibody/streptavidin-conjugated liposome LFA 
using PLA nanofibers, PLA-PEG nanofibers, and nitrocellulose (NC).  Anti-streptavidin antibodies were 
immobilized on the positive LFAs, but not the negative LFAs.  The “C” indicates a negative control that 
used C. parvum reporter probe liposomes instead of streptavidin liposomes to test for non-specific liposome 
binding.  PLA-PEG 2 samples were LFAs with thicker nanofiber mats than PLA-PEG 1. The signal was 
analyzed using ImageJ software. 
 
3.2 E. coli Sandwich Assay 
Using the optimal PLA-PEG nanofiber mat, a sandwich assay for E. coli O157:H7 was 
developed similarly to the single-step binding assay. Two antibodies specific to E. coli O157:H7 
were used. The capture antibody was immobilized onto the nanofiber mat, and the reporter 
antibody was conjugated with HRP. The signal was produced by adding a substrate for HRP, 1-
Step ABTS, that undergoes a color change to display a colorimetric result. Several different E. coli 
concentrations ranging from 5x103 to 7.5x105 cells/LFA were tested, and the colorimetric results 
were quantified using ImageJ software. A thorough dose-response curve, shown in Figure 3.4, was 
generated and the limit of detection was determined to be 1.9x104 cells. This limit of detection is 
comparable to other published immunoassays for bacteria.[21-25] The relevant negative controls in 
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these experiments tested for non-specific binding of both the E. coli cells and also the HRP-
conjugated reporter antibodies. The signal from non-specific binding of the reporter antibodies is 
represented as the zero concentration in the dose-response curve in Figure 3.4, and is negligible. 
Non-specific retention of E. coli in the nanofiber mats was tested at every E. coli concentration by 
omitting the capture antibody immobilization step. These results showed similar levels of signal 
as the zero-concentration samples, so importantly, the E. coli cells are not bound non-specifically 
to the PLA-PEG nanofiber mats. These results demonstrate that a successful sandwich 
immunoassay in an LFA format is possible using a platform of electrospun nanofibers. 
 
Figure 3.4: Nanofiber-Enhanced E. coli LFA Signal Dose-Response Curve. Anti-E. coli antibodies were 
immobilized on PLA-PEG nanofibers. A sandwich assay was performed in which E. coli bound to the 
capture antibody, and a reporter antibody conjugated with HRP bound to the captured E. coli cells to 
produce a colorimetric signal when substrate was added. The signal was analyzed using ImageJ. The limit 
of detection was calculated to be 1.9x104 cells. 
3.3 Nanofibers for Eliminating Non-Specific Binding 
The previously described thorough studies with respect to negative controls indicate the 
importance non-specific binding has especially in simple field and on-site assays. Even though 
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PEG is often times included in biological assays to avoid non-specific binding,[26] its presence in 
the PLA-PEG nanofibers was not sufficient for this purpose. We therefore investigated further 
approaches to eliminate non-specific binding not only via blocking reactions, but also more 
attractively via direct incorporation of anti-fouling polymers. Thus, an additional polymer, KB, 
was added to the PLA nanofibers. PLA-KB nanofibers completely eliminated the non-specific 
binding of the carboxylated SRB-encapsulating liposomes without the use of blocking agents 
likely due to repulsive forces between the nanofibers and liposomes. These nanofibers were 
compared to the non-specific binding of liposomes to unblocked and blocked PLA nanofibers. 
Figure 3.5a shows fluorescence images of unblocked and blocked PLA and unblocked PLA-KB 
nanofibers after they have been exposed to liposomes and washed. The PLA nanofibers had a very 
high level of non-specific binding, while the PLA-KB nanofibers had no visible non-specific 
interactions with the liposomes. The level of non-specific binding was quantified using ImageJ 
software, and Figure 3.5b shows the results of this analysis. The complete elimination of non-
specific binding makes these nanofibers an extremely attractive material for developing highly 
sensitive paper-based biological assays. 
4 Conclusions 
Paper-based platforms have become increasingly popular for developing point-of-care 
assays, as they are inexpensive, portable, disposable, easy to use, and require no external 
equipment. In this study, we have presented PLA-based electrospun nanofibers as a new material 
and alternative to the standard cellulose-based papers for use in paper-based assays such as LFAs. 
PLA-PEG nanofibers were synthesized and incorporated into an LFA, and a single-step binding 
assay using anti-streptavidin antibodies and streptavidin-conjugated SRB-encapsulating liposomes 
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Figure 3.5: Comparison of Non-Specific Liposome Binding to PLA-KB and Blocked and Unblocked PLA 
Nanofibers. 20µL of 100µM carboxylated liposomes wicked through PLA-KB nanofibers and PLA 
nanofibers, and the nanofibers were washed with 60µL of 1xHSS. Fluorescence images of nanofibers after 
testing (a), and a quantitative measurement of the non-specific liposome binding (b) are shown. 
 
was developed. The properties of the nanofiber mat and the conditions of the assay were optimized 
to achieve a result that was comparable to the nitrocellulose control. These nanofibers were then 
used to develop an enzymatic sandwich immunoassay for E. coli O157:H7 in the same LFA 
format. A dose-response curve for this assay determined the limit of detection to be 1.9x104 cells. 
Furthermore, an amphiphilic triblock terpolymer, KB, was incorporated into the PLA nanofibers 
and produced nanofibers with the ability to completely eliminate non-specific binding of 
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carboxylated SRB-encapsulating liposomes without the use of any blocking reagents. This 
attractive characteristic will be further investigated in the future with respect to its impact on the 
optimization of binding assay performances in the LFA format. These results not only demonstrate 
the general applicability of electrospun nanofiber mats in LFA formats, but provide insight into 
the immense possibilities offered by this new avenue of research. Novel materials will provide 
many opportunities for paper-based diagnostic development. Specific surface chemistries can be 
tailored to specific analytical challenges, notorious non-specific binding, especially obtained in 
complex matrices, can be overcome by smart material design. Here, investigations for covalent 
bonding of antibodies to the nanofibers will be required to fully explore their capabilities. 
Electrospun nanofibers will therefore have a significant impact on the field of paper-based 
microfluidic analytical devices with their desirable properties that are entirely controllable.  
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CHAPTER 4 
SUMMARY AND CONCLUSIONS 
 A key challenge in the miniaturization of nucleic acid detection techniques has been 
addressed in this research. Through the combination of an mRNA isolation and amplification step 
within the same location, a high sensitivity was achieved with the elimination of losses during 
sample transfer. Most important was the preparation of the microchannel surface to enable efficient 
isolation on one hand, and amplification without release of the mRNA from the surface on the 
other hand. We postulate that the effectiveness of the PAMAM dendrimer surface is not only due 
to the availability of more immobilization sites, but also due to an ideal surface in which the mRNA 
is not bound too tightly so as to prevent amplification or bound too loosely that it will be washed 
out of the channel. Furthermore, the surface chemistry presented an environment where there was 
no non-specific binding of the NASBA enzymes, which was a constant problem among previous 
devices.  
 Similar approaches to achieving high sensitivity through the exploitation of coupling 
isolation and amplification together within the same chamber, as well as amplifying the NAs 
without releasing them from the extraction media, have been reported previously. For example, 
Oblath et al. were able to detect as little as 300 fg of DNA using an aluminum oxide membrane 
on which the NAs remain immobilized during amplification.[1] Also, Zhang et al. achieved 
detection of a single bacterial cell using liquid-phase separation via phenol-chloroform extraction, 
followed by amplification within the same chamber.[2] When evaluating a device for NA isolation, 
it is important to determine how the NAs are being bound to the surface. One method for studying 
the bound NAs is through the use of fluorescence microscopy, which was used by Prinz et al. to 
determine where their target DNA resided in the microdevice.[3] Determining the yield of isolated 
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NAs from the initial sample is also necessary to assess the efficiency of the process, which is 
crucial for the detection of low concentrations of NAs. This can be measured using several 
methods. Many of the researchers that report low limits of detection use gel electrophoresis and a 
method for determining the approximate yield of NAs.[4-7] Fluorescent reporters can also be used[1, 
8], as well as commercial quantitative assays such as the PicoGreen assay.[9] For highly accurate 
determinations of the NA yield from sample with very low target concentrations, quantitative PCR 
can also be used.[10]  
 A simpler type of biosensor using lateral flow assay technology was developed and 
enhanced using electrospun PLA-based nanofibers incorporating functional polymers, which 
provided beneficial properties to improve performance. Although comparison of the nanofiber 
LFAs with nitrocellulose showed fairly equivalent performance, nanofiber mats are not yet ready 
to compete with existing, well-established nitrocellulose technology. Nitrocellulose mats can be 
manufactured to be extremely uniform and possess the same properties from mat to mat. However, 
this is not true of the nanofiber mats described here. Due to the uncontrollable environmental 
conditions during the electrospinning process, the pore size and thickness of the nanofiber mats 
greatly varied between batches. This resulted in variations in flow rate and immobilization of the 
capture antibodies, which affected the quality and consistency of results. Additionally, the 
nanofibers required an extra pre-wetting process before the antibodies could be immobilized, 
which poses further variances to the flow rate and capture efficiency. Nanofiber mats are also more 
difficult to handle, which makes them less user-friendly. 
Despite the challenges associated with using nanofibers in paper-based systems, the 
potential advantages are monumental, which makes them well worth studying further. First and 
foremost, nanofibers offer considerably higher surface area-to-volume ratios than other materials, 
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which greatly increases the number of available binding sites to immobilize biorecognition 
elements. This will have a significant impact on the sensitivity and efficiency of the device. The 
nanoscale dimensions of the nanofiber mats also allow for much faster mass transfer rates, which 
can lead to faster analysis and lower limits of detection. In addition, through simple adjustments 
of the electrospinning process, the characteristics of the nanofibers can be customized and easily 
tuned to the specific assay needs, which provides the opportunity to optimize the platform for 
highly sensitive detection. Furthermore, nanofibers can be spun from a very wide range of 
biocompatible materials with different properties. This enables countless functionalization options 
to facilitate the detection of limitless possible biological species. 
To allow nanofibers to be easier to use within paper-based analytical devices, some aspect 
of their fabrication, handling, and use should be simplified. Control of the atmospheric conditions 
in the electrospinning chamber is paramount to producing consistent, high quality nanofiber mats. 
Eliminating the need to transfer the nanofiber mat from the collector plate material to the paper-
based system is also beneficial not only in making the process more user-friendly, but also because 
it reduces contamination. This can be achieved by electrospinning the nanofibers directly on the 
assay backing material. The preparation of the nanofibers should also be simplified in that fewer 
steps should be required to perform the necessary modifications to facilitate the assay.  
A unique approach to simplifying the nanofiber preparation is through the incorporation of 
additional materials in the electrospinning dope. This has the potential to produce nanofiber mats 
that are completely ready to facilitate the bioassay without any additional preparation, which is the 
ultimate goal and advantage to using electrospun nanofibers. With this method, the nanofibers 
must possess wettability, available biorecognition species on their surface, and the ability to 
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prevent non-specific interactions. These are the aspects of nanofiber technology that must be 
explored further to realize their full potential in bioanalytical devices.  
Research presented here demonstrated the prevention of non-specific binding using 
functional anti-fouling polymers spun directly into the nanofibers. This technology should be 
studied further as non-specific binding is a current limitation of cellulose-based LFAs, and its 
elimination would result in lower detection limits for nanofiber-based assays. Incorporation of 
biological species, namely proteins, into the electrospinning dope itself has also been studied, but 
has yielded little success. The harsh conditions of the electrospinning process, including high heat 
and organic solvents, could be denaturing the proteins. Another possibility is that the proteins are 
being rendered unavailable due to their location within the nanofibers (not on the surface), or their 
orientation. Exploration into successful electrospinning of biorecognition elements into the 
nanofiber mats should be done as this would truly demonstrate the incredible potential of this 
technology.  
 Exploration of new techniques and materials is very important for developing novel 
biosensors that can overcome the limitations that restrict the use and efficacy of currently used 
technologies. Through the creation of innovative solutions to universal problems associated with 
existing µTAS designs, highly sensitive and specific biosensors can be realized for truly point-of-
care applications. 
  
   91 
1 References 
 
[1] E. A. Oblath, W. H. Henley, J. P. Alarie, J. M. Ramsey, Lab Chip 2013, 13, 1325–32. 
[2] R. Zhang, H.-Q. Gong, X. Zeng, C. Lou, C. Sze, Anal. Chem. 2013, 85, 1484–91. 
[3] C. Prinz, J. O. Tegenfeldt, R. H. Austin, E. C. Cox, J. C. Sturm, Lab Chip 2002, 2, 207–12. 
[4] J. S. Marcus, W. F. Anderson, S. R. Quake, Anal. Chem. 2006, 78, 3084–9. 
[5] D. Liu, G. Liang, Q. Zhang, B. Chen, Anal. Chem. 2013, 85, 4698–4704. 
[6] C.-H. Wang, K.-Y. Lien, T.-Y. Wang, T.-Y. Chen, G.-B. Lee, Biosens. Bioelectron. 2011, 
26, 2045–52. 
[7] C.-H. Wang, K.-Y. Lien, J.-J. Wu, G.-B. Lee, Lab Chip 2011, 11, 1521–31. 
[8] K.-Y. Lien, C.-J. Liu, P.-L. Kuo, G.-B. Lee, Anal. Chem. 2009, 81, 4502–9. 
[9] H. Tian, A. F. Hühmer, J. P. Landers, Anal. Biochem. 2000, 283, 175–91. 
[10] M. Kokoris, M. Nabavi, C. Lancaster, J. Clemmens, P. Maloney, J. Capadanno, J. Gerdes, 
C. F. Battrell, Methods 2005, 37, 114–9. 
 
